fibrinogen has been researched along with Genetic Predisposition in 220 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.45) | 18.7374 |
1990's | 9 (4.09) | 18.2507 |
2000's | 104 (47.27) | 29.6817 |
2010's | 90 (40.91) | 24.3611 |
2020's | 16 (7.27) | 2.80 |
Authors | Studies |
---|---|
Abbadessa, G; Armetta, I; Bonavita, S; D'Elia, G; Di Pietro, A; Lavorgna, L; Lus, G; Miele, G; Palladino, R; Signoriello, E; Sparaco, M; Trojsi, F | 1 |
Ceznerová, E; Kaufmanová, J; Kotlín, R; Loužil, J; Sovová, Ž; Štikarová, J; Suttnar, J | 1 |
Fang, Y; Gao, N; Guo, Y; Li, GF; Qiao, H; Wang, C; Wang, T; Wen, Q; Xu, C; Yang, L; Zhang, Y; Zhou, J | 1 |
Atkinson, J; Hu, Z; Huan, T; Java, A; Pozzi, N; Schroeder, MC; Seddon, JM | 1 |
Geng, C; Gu, R; Wang, C; Wang, H; Wang, J; Zhu, Z | 1 |
Asselta, R; Caccia, S; Kubisz, P; Lasabova, Z; Loderer, D; Simurda, T; Skornova, I; Snahnicanova, Z; Stasko, J; Zolkova, J | 1 |
Casini, A; Undas, A | 1 |
Li, Q; Liu, W; Sun, Y; Zhang, B | 1 |
Duan, Q; Hong, C; Lu, Q; Luo, T; Lv, J; Shu, S; Zhang, Q; Zhao, D; Zhao, W | 1 |
Bakker, B; Blom, AM; de Breuk, A; de Jong, EK; de Jong, S; den Hollander, AI; Hoyng, CB; Nilsson, SC; van den Heuvel, LP; van der Kar, NCAJ; Volokhina, EB | 1 |
Ahmadi, A; Baghaipour, MR; Dorgalaleh, A; Ghasemi, JB; Jazebi, M; Rezaei Makhouri, F; Rezvani, MR; Safa, M; Tabibian, S; Tavasoli, B; Zaker, F | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Auger, I; Balandraud, N; Roudier, J | 1 |
Cruz-Flores, S; Cushman, M; Kamin Mukaz, D; McCullough, LD; Zakai, NA | 1 |
Dounavi, ME; Low, A; Mak, E; Markus, HS; Muniz-Terrera, G; O'Brien, JT; Ritchie, CW; Ritchie, K; Stefaniak, JD; Su, L | 1 |
Bánovčin, P; Grendár, M; Kolková, Z; Kostková, M; Motyková, K; Suroviaková, S; Vojtková, J | 1 |
Hong, WJ; Jiang, YQ; Li, WL; Luo, S; Ni, H; Wang, WF; Wang, XW; Wu, LN; Zheng, HB; Zhu, F | 1 |
Chauhan, AK; Chorawala, MR; Dhanesha, N; Doddapattar, P; Kokame, K; Lentz, SR; Nayak, MK; Staber, JM | 1 |
Kutlu, G; Sirin, B; Yılmaz, M; Yılmaz, N; Yılmaztekin, S | 1 |
Brennan, S; Brennan, SO; Laurie, AD | 1 |
Braekkan, SK; Frazer, KA; Hansen, JB; Hindberg, K; Horvei, LD; Rosendaal, FR; Smith, EN; Solomon, T | 1 |
Arai, S; Matsuda, K; Okumura, N; Sugano, M; Taira, C; Uehara, T | 1 |
Li, ZG; Liu, G; Wu, HW | 1 |
Chen, L; Hu, X; Huang, J; Li, Y; Qiao, S; Wang, J; Wu, J; Xu, S | 1 |
Fidalgo, T; Manco, L; Martinho, P; Ribeiro, ML; Sarmento, AB; Silva, C | 1 |
Bi, P; Dong, Y; Guo, Y; Jiang, A; Li, X; Luo, H; Zhang, B | 1 |
Braekkan, SK; Evensen, LH; Gabrielsen, ME; Hansen, JB; Hveem, K; Mathiesen, EB; Morelli, VM; Njølstad, I; Rinde, LB; Rosendaal, FR; Småbrekke, B | 1 |
Petrovič, D | 1 |
Guo, J; He, G; He, L; Lei, L; Lu, Q; Wang, Y; Xiao, J; Xu, Y; Yin, Y; Yu, L; Zhang, J; Zhao, J | 1 |
Bandinelli, S; Basu, S; Baumert, J; Becker, DM; Becker, LC; Bevan, S; Bis, JC; Boerwinkle, E; Boomsma, DI; Buckley, BM; Campbell, H; Chambers, JC; Chasman, D; Chen, MH; Clarke, R; Cucca, F; Curb, JD; Danesh, J; Davies, G; de Geus, EJ; Deary, IJ; Dehghan, A; Dichgans, M; Eaton, CB; Erdmann, J; Eriksson, JG; Eriksson, P; Ferrucci, L; Folkersen, L; Folsom, AR; Fornage, M; Franco, OH; Franco-Cereceda, A; Franzosi, MG; Gieger, C; Goel, A; Grant, PJ; Green, D; Gross, M; Grotevendt, A; Guo, X; Hamsten, A; Haritunians, T; Harris, SE; Hayward, C; Hofman, A; Homuth, G; Hopewell, JC; Hottenga, JJ; Huang, J; Huffman, JE; Ikram, MA; Illig, T; Jacobs, D; Johnson, AD; Jukema, JW; Kathiresan, S; Kocher, T; Koenig, W; Kolcic, I; Kooner, JS; Lahti, J; Liewald, DC; Liu, S; Lopez, LM; Lowe, GD; Lumley, T; Mälarstig, A; Markus, HS; McArdle, WL; McKnight, B; Mehra, R; Morange, PE; Mosley, TH; Naitza, S; Navarro, P; Nelson, CP; O'Donnell, CJ; Oudot-Mellakh, T; Palotie, A; Peters, A; Polasek, O; Psaty, BM; Pulanic, D; Räikkönen, K; Redline, S; Reilly, MP; Reiner, AP; Ridker, PM; Rivadeneira, F; Rose, LM; Rothwell, PM; Rotter, JI; Rudan, I; Rudnicka, AR; Rumley, A; Sabater-Lleal, M; Saleheen, D; Samani, NJ; Sanna, S; Sattar, N; Schlessinger, D; Schunkert, H; Seedorf, U; Sennblad, B; Seshadri, S; Shin, SY; Silveira, A; Smith, NL; Song, J; Soranzo, N; Spector, TD; Starr, JM; Steri, M; Stott, DJ; Strachan, DP; Strawbridge, RJ; Sudlow, CL; Swords Jenny, N; Tanaka, T; Tang, W; Tarasov, KV; Taylor, KD; Teichert, M; Teumer, A; Tofler, GH; Tracy, RP; Tregouet, D; Trompet, S; Uitterlinden, AG; van Dongen, J; Völzke, H; Wallace, R; Wallaschofski, H; Watkins, H; Widen, E; Wild, SH; Willemsen, G; Williams, FM; Wilson, JF; Witteman, JC; Wright, AF; Yanek, LR; Yao, J; Zemunik, T | 1 |
Chaparzadeh, N; Farzadi, L; Ghasemzadeh, A; Ghorbian, S; Kafshdooz, T; Poursadegh Zonouzi, A; Sadaghiani, MM; Sakhinia, E; Sakhinia, M | 1 |
Grover, A; Kumar, A; Kumar, P; Prasad, K; Sagar, R; Sahu, JK; Srivastava, AK; Vivekanandhan, S | 1 |
Bang, HJ; Choi, KS; Chung, JH; Kang, H; Kim, SK; Kim, SY; Kwack, K; Lee, SK; Nam, M; Ro, M; Won, S; Yang, JW | 1 |
Bakirci, EM; Borekci, A; Kalkan, K; Karakoyun, S; Sevimli, S; Topcu, S; Vançelik, S | 1 |
Atamaniuk, J; Dossenbach-Glaninger, A; Oberkanins, C; van Trotsenburg, M | 1 |
Algarni, KD; Cohen, EA; Deb, S; Desai, ND; Dubbin, JD; Elituv, R; Fremes, SE; Liu, PP; McManus, BM; Radhakrishnan, S; Rajamani, K; Schwartz, L; Singh, SK; Vincent, J; Yanagawa, B | 1 |
Gu, L; Guo, X; Huang, G; Liang, B; Long, J; Su, L; Tan, J; Wu, G; Yan, Y | 1 |
Gu, L; Huang, G; Liang, B; Liu, W; Su, L; Tan, J; Wu, G; Yan, Y | 1 |
Chen, QL; Hu, XF; Jin, XP; Li, C; Li, WL; Wang, F; Wang, WF; Zheng, Z; Zhu, F; Zhu, M | 1 |
Biswas, A; Ivaskevicius, V; Oldenburg, J; Thomas, A | 1 |
Kopyta, I; Sarecka-Hujar, B; Sordyl, J; Sordyl, R | 1 |
Anaya, JM; Arango-Guerrero, MT; Chua, KH; Ghosh, K; Harley, JB; Kim-Howard, X; Looger, LL; Maiti, AK; Motghare, P; Nath, SK; Niewold, TB; Pradhan, V; Sun, C | 1 |
Chang, L; Li, HH; Tao, SB; Yan, HQ; Yuan, B; Zhang, LJ; Zhao, JH | 1 |
Dardiotis, E; Dziedzic, T; Fountas, K; Gąsowski, J; Golenia, A; Hadjigeorgiou, G; Jagiełła, J; Klimkowicz-Mrowiec, A; Paterakis, K; Pera, J; Słowik, A; Wnuk, M | 1 |
Arai, S; Fujikawa, Y; Hiroshima, Y; Ichikawa, N; Kirihara, T; Kobayashi, H; Kurihara, T; Okumura, N; Sato, K; Soya, K; Sumi, M; Takeda, W; Ueki, T; Ueno, M | 1 |
Erkinjuntti, T; Karhunen, PJ; Kaste, M; Martiskainen, M; Oksala, A; Oksala, N; Pohjasvaara, T | 1 |
Brennan, SO; Laurie, A | 1 |
Bauduer, F | 1 |
Ababneh, OH; Abu-Ameerh, MA; Al-Khateeb, MA; Albdour, MD; Awidi, AS; Awidi, MA; Bener, A; Dweik, MR; Gharaibeh, AM; Saleh, MM | 1 |
Banz, V; Candinas, D; Demarmels Biasiutti, F; Fort, A; Furer, C; Keogh, A; Kühni-Boghenbor, K; Lämmle, B; Neerman-Arbez, M; Stoffel, MH; Stroka, D; Vu, D | 1 |
Chen, XY; Cheng, SY; Wang, RD; Zeng, JW; Zhao, YD | 1 |
Afrasiabi, A; Asselta, R; Borhany, M; Duga, S; Guella, I; Menegatti, M; Peyvandi, F; Platè, M; Robusto, M; Shamsi, T; Soldà, G | 1 |
Bojiang, L; Li, J; Tong, L; Wenjin, P; Xiaomin, H; Xin, L; Yingwu, L; Yu, W; Yunyun, W | 1 |
Brennan, SO; Laurie, A; Smith, M | 1 |
Shchukin, SP | 1 |
Luo, TY; Zhang, XF | 1 |
Harris, CL; Heurich, M; Llorca, O; López-Perrote, A; López-Trascasa, M; Martínez-Barricarte, R; Morgan, BP; Pinto, S; Rodríguez de Córdoba, S; Sánchez-Corral, P; Tortajada, A | 1 |
Cai, H; Cai, Y; Chen, Z; Qi, H; Tan, L; Wu, G | 1 |
Asselta, R; Braidotti, P; Caccia, S; D'Antiga, L; Duga, S; Maggiore, G; Nastasio, S; Perisic, VN; Peyvandi, F; Robusto, M | 1 |
Acosta, D; Caldés, T; de la Hoya, M; de Las Heras, N; Díaz-Millán, I; Díaz-Rubio, E; Lahera, V; López Farré, A; Melander, O; Modrego, J; Perez-Segura, P; Rico Zalba, LA; Santos-Sancho, JM; Zamorano-León, JJ | 1 |
Biswas, A; Griesmacher, A; Hohenstein, K; Ivaškevičius, V; Oldenburg, J; Weigel, G; Würtinger, P; Zehetbauer, S | 1 |
Bergh, E; Forman, EJ; Franasiak, JM; Lonczak, A; Patounakis, G; Scott, RT; Tao, X; Treff, N | 1 |
Chen, WM; Coull, B; Dupuis, J; Dzhivhuho, G; Furie, KL; Gogarten, SM; Hsu, FC; Keene, KL; Lin, H; Madden, EB; Malik, R; Mehndiratta, P; Nelson, S; Rich, SS; Rowles, JL; Sale, MM; Seshadri, S; Southerland, AM; Williams, SR; Worrall, BB | 1 |
Erdem, HB; Eroz, R; Ozdemir, G; Ozel, L; Sahin, I; Tasdemir, S; Tatar, A | 1 |
Ding, SF; Jiang, QJ; Jin, Y; Qiu, CG; Zheng, QS | 1 |
Jin, YH; Liu, MN; Shen, XL; Wang, MS; Xu, XM; Zhao, ZS; Zheng, JY | 1 |
Biswas, A; Davoli, M; Detarsio, G; Gupta, S; Ivaškevičius, V; Oldenburg, J; Pérez, S; Quartara, A; Raviola, M; Rühl, H | 1 |
Alessandrini, F; Brandimarti, F; Catalani, C; De Angelis, L; Galeazzi, R; Gesuita, R; Giorgetti, R; Giovagnetti, S; Pesaresi, M; Righi, E; Tagliabracci, A | 1 |
Liu, R; Ma, Y; Rao, W; Shi, J; Su, Y; Yang, G; Yu, Q; Yu, Y; Zhang, H; Zhang, S; Zhou, N | 1 |
Brungs, T; Casini, A; de Moerloose, P; Lavenu-Bombled, C; Neerman-Arbez, M; Vilar, R | 1 |
Gijbels, MJJ; Heestermans, M; Ouweneel, AB; Reitsma, PH; Van Eck, M; van Vlijmen, BJM; Verwilligen, RAF | 1 |
Li, J; Liu, L; Sheng, W; Xu, X | 1 |
Favorova, OO; Gusev, EI; Martynov, MIu; Nikonova, AA; Parfenov, MG; Serdiuk, IE; Sudomoina, MA | 1 |
Benachi, A; Blouin, J; Dürrbach, A; Fakhouri, F; Frémeaux-Bacchi, V; Grünfeld, JP; Hourmant, M; Jablonski, M; Knebelmann, B; Lepercq, J; Pirson, Y | 1 |
Bos, MJ; Breteler, MM; Cheung, EY; de Maat, MP; Hofman, A; Koudstaal, PJ; Leebeek, FW | 1 |
Almasy, L; Best, LG; Cole, S; Diego, VP; Goring, H; Haack, K; Laston, S; Lee, ET; Li, X; MacCluer, J; North, KE; Palmieri, V; Tracy, RP; Umans, JG | 1 |
Chen, J; Chen, W; Chen, X; Jin, L; Xu, M | 1 |
Baldari, F; Bellander, T; Breitner, S; Chrysohoou, C; Greven, S; Heid, IM; Illig, T; Jacquemin, B; Koenig, W; Lanki, T; Nyberg, F; Pekkanen, J; Peters, A; Pistelli, R; Rückerl, R; Schneider, A; Stefanadis, C; Sunyer, J; Wichmann, HE | 1 |
Bové, A; Cervera, R; de la Red, G; Espinosa, G; Monteagudo, J; Plaza, J; Reverter, JC; Tàssies, D | 1 |
Baumert, J; Döring, A; Gohlke, H; Grallert, H; Illig, T; Koenig, W; Kolz, M; Peters, A; Wichmann, HE | 1 |
Kazakevich, EV; Serdechnaia, EV; Tatarskiĭ, BA | 1 |
Baccarelli, A | 1 |
Favorova, OO; Gusev, EI; Iasamanova, AN; Kolesnikova, TI; Martynov, MIu; Nikonova, AA; Parfenov, MG; Serdiuk, IE; Sudomoina, MA | 1 |
Dahl, M; Nordestgaard, BG | 1 |
Guo, X; Zhang, D; Zhang, X | 1 |
Lacolley, P; Regnault, V; Safar, ME | 1 |
Gohil, R; Peck, G; Sharma, P | 1 |
Aggermann, T; Binder, S; Frantal, S; Haas, P; Krugluger, W; Oberkanins, C; Pühringer, H; Steindl, K | 1 |
Cetin, A; Cetin, M; Kocak, N; Ozdemir, O; Ozen, F; Yenicesu, C; Yenicesu, GI; Yildiz, C | 1 |
Bielinski, SJ; Carlson, CS; Fornage, M; Gross, MD; Jacobs, DR; Jenny, NS; Lange, LA; Nickerson, DA; Reiner, AP; Tracy, RP; Walston, J; Williams, OD | 1 |
Carty, CL; Cushman, M; Heagerty, P; Heckbert, SR; Jarvik, GP; Lange, LA; Reiner, AP; Tracy, RP | 1 |
Cherny, SS; Cheung, BM; Jiang, CQ; Lam, KS; Lam, TH; Ong, KL; Sham, PC; Thomas, GN; Tso, AW | 1 |
Feldmann, M; Fisher, B; Kinloch, A; Lundberg, K; Malmström, V; Venables, PJ; Wegner, N | 1 |
Barbieri, M; Boccardi, V; Esposito, A; Marfella, R; Paolisso, G; Papa, M; Portoghese, M; Rizzo, MR | 1 |
Bukowska, H; Chełstowski, K; Honczarenko, K; Jastrzębska, M; Kozłowska-Wojciechowska, M; Makarewicz-Wujec, M; Masztalewicz, M; Mierzecki, A | 1 |
Dong, RZ; Gong, JE; Gu, WP; Liang, J; Song, XM; Tang, CL; Xiao, H; Yang, QD | 1 |
Gao, J; Wang, HY; Wu, NJ; Zhang, SH | 1 |
Brennan, SO; Conard, K; Davis, RL; Furuya, KN; Savo, A | 1 |
Chen, Z; Hinohara, K; Inoue, Y; Kasahara, Y; Kimura, A; Nakajima, T; Sakao, S; Tanabe, N; Tatsumi, K | 1 |
Biron-Andréani, C; Boulot, P; de Moerloose, P; Fish, RJ; Nagaswami, C; Neerman-Arbez, M; Reyftmann, L; Vorjohann, S; Weisel, JW | 1 |
Brennan, SO; Davis, RL | 1 |
Delaney, JA; Folsom, AR; Green, D; Ho, LA; Jacobs, DR; Johnson, AD; Keating, BJ; Lange, EM; Lange, LA; Li, Y; O'Donnell, CJ; Palmer, C; Redline, S; Reiner, AP; Smith, NL; Tang, W; Taylor, HA; Taylor, KC; Tofler, G; Tracy, RP; Wassel, CL; Wilson, JG; Yang, Q | 1 |
Ashavaid, TF; Dalal, JJ; Kondkar, AA; Nair, KG; Ponde, CK; Rajani, R; Shalia, KK; Todur, SP | 1 |
Brennan, SO; Davis, RL; Oliver, J | 1 |
Buggage, R; Chakravarthy, U; Evans, C; Fletcher, A; Mitchell, P; Piault, E; Pleil, A; Wong, TY; Zlateva, G | 1 |
Ay, C; Dunkler, D; Horvath, B; Mannhalter, C; Pabinger, I; Pabinger, M; Quehenberger, P; Tiedje, V; Zielinski, C | 1 |
Hamsten, A; Joutsi-Korhonen, L; Kaprio, J; Kaye, SM; Kotronen, A; Lassila, R; Pietiläinen, KH; Rissanen, A; Silveira, A; Yki-Järvinen, H | 1 |
Caulfield, MJ; Kiechl, S; Morris, GE; Motterle, A; Pender, SL; Willeit, J; Xiao, Q; Ye, S | 1 |
Du, X; Hu, Z; Liu, B; Liu, Y; Ma, M; Xia, J; Xu, H; Yang, Q; Zeng, Y; Zhang, L | 1 |
Drenos, F; Humphries, SE; Ken-Dror, G; Kivimaki, M; Kumari, M | 1 |
Dimitroulas, T; Douglas, KM; Kitas, GD; Panoulas, VF; Smith, J | 1 |
Doğan, A; Erdogan, D; Icli, A; Varol, E | 1 |
Anuurad, E; Berglund, L; Enkhmaa, B; Gungor, Z; Kim, K; Zhang, W | 1 |
Alfredsson, L; Bengtsson, C; Holmdahl, R; Israelsson, L; Jiang, X; Kallberg, H; Kessel, C; Kharlamova, N; Klareskog, L; Lundberg, K; Padyukov, L; Pollak-Dorocic, I; Reed, E | 1 |
Chegodaev, DA; Kovtun, OP; L'vova, OA | 1 |
Hellmann, A; Mital, A; Neerman-Arbez, M; Undas, A | 1 |
Chu, JY; Huang, XQ; Li, JM; Lin, KQ; Qi, L; Sun, H; Yang, ZQ | 1 |
Adamo, EB; Alibrandi, A; Altavilla, D; Atteritano, M; Bitto, A; Caccamo, D; Currò, M; D'Anna, R; Ferlazzo, N; Ientile, R; Marini, H; Polito, F; Squadrito, F | 1 |
Bova, M; Caruso, C; Caruso, M; Forte, GI; Lio, D; Massenti, MF; Novo, S; Palmeri, M; Scola, L; Vaccarino, L; Vitale, F; Vitale, S | 1 |
Adam, F; Berrou, E; Bryckaert, M; Coupry, I; Favier, R; Fergelot, P; Goizet, C; Jandrot-Perrus, M; Kauskot, A; Lebret, M; Nurden, A; Nurden, P; Rosa, JP | 1 |
Agustí, A; Bakke, P; Beaty, TH; Celli, B; Cho, MH; Coxson, H; Crapo, JD; Gulsvik, A; Hersh, CP; Kim, DK; Kong, X; Litonjua, A; Lomas, DA; MacNee, W; Miller, BE; Qiu, W; Rennard, S; Riley, JH; Silverman, EK; Tal-Singer, R; Vestbo, J; Wouters, E; Yates, JC | 1 |
Baeten, D; Cantaert, T; Tak, PP; Teitsma, C | 1 |
Brennan, SO; Ho, LL; Zebeljan, D | 1 |
Berlit, P; Harbrecht, U; Klockgether, T; Kraus, JA; Müller, J; Nahser, HC; Stüper, BK | 1 |
Heinonen, S; Hiltunen, M; Laasanen, J; Mannermaa, A; Punnonen, K | 1 |
Sehnal, E; Slany, J | 1 |
Grant, P; Mansfield, M; Mills, J | 1 |
Chełstowski, K; Foltynska, A; Honczarenko, K; Jastrzebska, M; Naruszewicz, M; Torbus-Lisiecka, B | 1 |
Asselta, R; Duga, S; Malcovati, M; Peyvandi, F; Spena, S; Tenchini, ML | 1 |
van der Bom, JG | 1 |
Cichocki, L; Forjanics, A; Gasser, R; Köppel, H; Pilger, E; Renner, W | 1 |
Baretton, G; Carmeliet, P; Castellino, F; Erlich, J; Fernandes, A; Gutstein, D; Kehrle, B; Luther, T; Mackman, N; Melis, E; Parry, G; Pawlinski, R; Pedersen, B; Pyo, R; Rosen, E; Taubman, M; Zhang, J | 1 |
De Staercke, C; Hooper, WC | 1 |
Abu-Libdeh, B; Bouchardy, I; Morris, MA; Neerman-Arbez, M; Vu, D | 1 |
Erkinjuntti, T; Ilveskoski, E; Karhunen, PJ; Kaste, M; Kunnas, T; Laippala, P; Mäntylä, R; Martiskainen, M; Mikkelsson, J; Pohjasvaara, T | 1 |
Cupples, LA; D'Agostino, RB; Feng, D; Larson, MG; Levy, D; Lindpaintner, K; O'Donnell, CJ; Tofler, GH; Yang, Q | 1 |
Bickel, C; Blankenberg, S; Cambien, F; Georges, JL; Hafner, G; Meyer, J; Nicaud, V; Poirier, O; Rupprecht, HJ; Tiret, L | 1 |
Watzke, HH | 1 |
Goracy, I; Jastrzebska, M; Naruszewicz, M | 1 |
Dossenbach-Glaninger, A; Finsterer, J; Hopmeier, P; Krugluger, W; Stöllberger, C | 1 |
Davey Smith, G; Ebrahim, S; Harbord, R | 1 |
Camilleri, RS; Cohen, H; Everington, T; Peebles, D; Portmann, C | 1 |
Bi, S; Li, G; Pan, S; Wang, D; Wen, S | 1 |
Alte, D; Felix, SB; John, U; Robinson, DM; Schwahn, C; Völzke, H | 1 |
Corral, J; del Rey, ML; González-Conejero, R; Lip, GY; Marín, F; Roldán, V; Sogorb, F; Vicente, V | 1 |
Antoniades, C; Brown, M; Chrysohoou, C; Panagiotakos, DB; Pitsavos, C; Skoumas, J; Stefanadis, C | 1 |
Chudakova, DA; Minushkina, LO; Nosik, VV; Zateĭshchikov, DA | 1 |
Aillaud, MF; di Minno, G; Eriksson, P; Hamsten, A; Hawe, E; Humphries, S; Juhan-Vague, I; Mannila, MN; Margaglione, M; Mussoni, L; Silveira, A; Tremoli, E; Yudkin, J | 1 |
Chetstowski, K; Ciechanowicz, A; Foltynska, A; Goracy, I; Janczak-Bazan, A; Jastrzebskal, M; Naruszewicz, M; Wesotowska, T; Widecka, K | 1 |
Kirbis, J; Milutinović, A; Poglajen, G | 1 |
Almasy, L; Blangero, J; Buil, A; Fontcuberta, J; Lathrop, M; Soria, JM; Souto, JC | 1 |
Ijzerman, RG | 1 |
Broom, I; McNeill, G; Mutch, WJ; Tuya, C | 1 |
Berthier-Schaad, Y; Coresh, J; Fallin, MD; Fink, NE; Klag, MJ; Liu, Y; Smith, MW; Tracy, RP | 1 |
Ebrahim, S; Harbord, R; Milton, J; Smith, GD; Sterne, JA | 1 |
Bukowska, H; Honczarenko, K; Jastrzebska, M; Mierzecki, A; Millo, B; Torbus-Lisiecka, B | 1 |
Gao, J; Li, HF; Pei, HZ; Wang, SJ; Yuan, XD | 1 |
Ginsburg, D | 1 |
Chang, CJ; Hsu, LA; Hsu, TS; Ko, YL; Lee, YS; Teng, MS; Tsai, CT; Wu, S | 1 |
Friedlander, Y; Kark, JD; Sinnreich, R; Siscovick, DS; Tracy, RP | 1 |
Bevelacqua, V; Bevelacqua, Y; Libra, M; Malaponte, G; Mazzarino, MC; Navolanic, PM; Polesel, J; Signorelli, SS; Stivala, F; Talamini, R | 1 |
Ericsson, CG; Eriksson, P; Hamsten, A; Mannila, MN; Silveira, A | 1 |
Brennan, SO; Lowen, R; Matsunaga, A; Mosesson, MW; Siebenlist, KR | 1 |
Ma, AJ; Pan, XD; Xing, Y; Zhang, CS; Zhang, YN | 1 |
Camargo, AL; Gabriel, SB; Hirschhorn, JN; Kathiresan, S; Larson, MG; O'Donnell, CJ; Tofler, GH; Yang, Q | 1 |
Smith, GD | 1 |
Marie, B; Maumus, S; Siest, G; Vincent-Viry, M; Visvikis-Siest, S | 1 |
Boerwinkle, E; Carlson, CS; Carty, CL; Fornage, M; Jaquish, CE; Lewis, CE; Nickerson, DA; Reiner, AP; Rice, K; Rieder, MJ; Siscovick, DS; Smith, JD; Tracy, RP; Wan, JY; Williams, OD | 1 |
Liu, YM; Mao, YL; Pang, BS; Wang, C; Xiao, B; Yang, YH; Zhai, ZG | 1 |
Cai, WW; Chen, XD; Cheng, S; Huang, SX; Liang, L; Liao, XP; Liu, GX; Long, ZG; Sun, C; Tang, XL; Wang, XY; Wen, GQ; Xiao, F | 1 |
De Stavola, BL; Humphries, SE; Meade, TW | 1 |
Dörner, T; Hoppe, B; Kiesewetter, H; Salama, A; Tolou, F | 1 |
Blouin, J; Fakhouri, F; Frémeaux-Bacchi, V; Grünfeld, JP; Knebelmann, B; Lequintrec, M; Lesavre, P; Noël, LH; Salomon, R; Servais, A | 1 |
Boguch, JM; Carlson, CS; Duan, H; Hatsukami, TS; Heagerty, PJ; Jarvik, GP; Nickerson, DA; Nord, AS; Pritchard, DK; Ranchalis, J; Rieder, MJ; Schwartz, SM | 1 |
Eriksson, P; Farrell, DH; Hamsten, A; Kazmierczak, SC; Lovely, RS; Mannila, MN; Samnegård, A; Silveira, A | 1 |
de Maat, MP; Hofman, A; Kardys, I; Uitterlinden, AG; Witteman, JC | 1 |
Bertina, RM; de Visser, MC; Houwing-Duistermaat, JJ; Rosendaal, FR; van Minkelen, R; Vos, HL | 1 |
Grünbacher, G; Köppel, H; Marx-Neuhold, E; März, W; Pilger, E; Renner, W; Wascher, T; Weger, W | 1 |
Gong, R; Li, L; Liu, Z | 1 |
Alberti, C; Boudailliez, B; Bouissou, F; Deschenes, G; Dragon-Durey, MA; Fischbach, M; Fremeaux-Bacchi, V; Gie, S; Guest, G; Loirat, C; Macher, MA; Morin, D; Niaudet, P; Nivet, H; Sellier-Leclerc, AL; Tsimaratos, M | 1 |
Chen, WQ; Chen, XC; Han, CL; Xu, MT; Zhou, W | 1 |
Bachoo, P; Brittenden, J; Croal, B; Ford, I; Greaves, M; Hillis, GS; Rajagopalan, S | 1 |
Chevreaud, C; de Mazancourt, P; French, P; Hanss, M; Négrier, C | 1 |
Carter, AM; Cymbalista, CM; Grant, PJ; Spector, TD | 1 |
Galanakis, DK; Henschen, A; Hubbs, D; Nagaswami, C; Neerman-Arbez, M; Scheiner, T; Weisel, JW | 1 |
Allaart, CF; Breedveld, FC; Cheung, K; de Vries, RR; de Vries-Bouwstra, JK; Drijfhout, JW; Huizinga, TW; Ioan-Facsinay, A; Pruijn, GJ; Toes, RE; van der Helm-van Mil, AH; Verpoort, KN | 1 |
Dudbridge, F; Eikenboom, JC; Goldsmith, K; Long, L; Morrell, NW; Pepke-Zaba, J; Suntharalingam, J; Toshner, MR; Treacy, CM; van Marion, V | 1 |
Ozgen, AG; Saraç, F; Tüzün, M; Yilmaz, C | 1 |
Archetti, S; Assanelli, D; Grassi, M; Kisialiou, A; Mozzini, C; Pezzini, A | 1 |
Carlson, CS; Carty, CL; Cushman, M; Durda, JP; Hindorff, LA; Jenny, NS; Jones, D; Lange, LA; Nickerson, D; Reiner, AP; Rice, K; Tracy, RP; Walston, J | 1 |
Chae, JS; Choi, D; Heo, YM; Huttner, K; Hyun, YJ; Jang, Y; Kim, OY; Koh, SJ; Lee, JH; Shin, DJ | 1 |
Doggen, CJ; Rosendaal, FR; van der Bom, JG; van der Krabben, MD | 1 |
Dash, D; John, S; Kakkar, VV; Maitra, A; Ramanna, JK; Rao, VS; Sannappa, PR; Shanker, J | 1 |
Bergner, R; Eriksson, M; Hegenbart, U; Lohse, P; Röcken, C; Schmidt, H; Schönland, S | 1 |
Folsom, AR; Greenberg, B; Harada, S; Iida, M; Iso, H; Koike, K; Komachi, Y; Sato, S; Shimamoto, T; Winkelmann, JC | 1 |
Assmann, G; Funke, H; Heinrich, J; Köhler, E; Rust, S; Schönfeld, R; Schulte, H | 1 |
Cappucci, G; Colaizzo, D; Di Minno, G; Grandone, E; Margaglione, M; Pirro, L; Vecchione, G | 1 |
Avenirova, EA; Ivanov, SN; Liberman, IS; Vinogradova, TV | 1 |
Carter, AM; Catto, AJ; Grant, PJ | 1 |
D'Orazio, A; De Lucia, D; Di Castelnuovo, A; Donati, MB; Iacoviello, L; Negrini, R; Zito, F | 1 |
Chan, LC; Janus, ED; Lam, KS; Ma, OC; Wat, NM | 1 |
Cloutier, G; Genest, J; Weng, X | 1 |
Grant, PJ; Lane, DA | 1 |
Byzova, TV; Plow, EF | 1 |
Bray, PF; Goldschmidt-Clermont, PJ; Roos, C; Vijayan, KV | 1 |
Austin, H; Dilley, A; Ellingsen, D; Evatt, B; Hooper, WC; Lally, C; Rawlins, P; Silva, V; Wenger, NK; Wideman, C | 1 |
Aston, CE; Kamboh, MI; Low, PS; Saha, N | 1 |
Bønaa, KH; Joakimsen, O; Stensland-Bugge, E | 1 |
Amadei, N; Baracho, GV; Bastos, W; Florido, MP; Isaac, L; Nudelman, V | 1 |
D'Agostino, RB; Feng, D; Larson, MG; Levy, D; Lindpaintner, K; Lipinska, I; Mittleman, M; Muller, JE; O'Donnell, CJ; Sutherland, PA; Tofler, GH | 1 |
Brennan, SO; Callea, F; Fabbretti, G; George, PM; Kudryk, B; Medicina, D | 1 |
Halonen, P; Kareinen, A; Laakso, M; Lehto, S; Viitanen, L | 1 |
Humphries, SE; Montgomery, HE; Talmud, PJ | 1 |
Heng, CK; Hong, S; Liu, Y; Low, PS; Saha, N | 1 |
Benedetta Donati, M; Iacoviello, L; Vischetti, M; Zito, F | 1 |
Blumenthal, RS; Braunstein, JB; Bray, P; Gerstenblith, G; Kershner, DW; Post, WS; Schulman, SP | 1 |
Flavell, DM; Hawe, E; Humphries, SE; Jamshidi, Y; MacCallum, PK; Meade, TW | 1 |
Bukowska, H; Chelstowski, K; Honczarenko, K; Jastrzebska, M; Naruszewicz, M; Torbus-Lisiecka, B | 1 |
Brennan, PJ; Cruickshank, JK; Dawson, SJ; Green, FR; Hamsten, A; Henney, AM; Kelleher, CH; Lane, A; Thomas, AE; Wilkes, HC | 1 |
Comp, PC | 1 |
31 review(s) available for fibrinogen and Genetic Predisposition
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Identifying Genetic and Biological Determinants of Race-Ethnic Disparities in Stroke in the United States.
Topics: Biomarkers; Black or African American; Blood Coagulation; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Genetic Predisposition to Disease; Health Status Disparities; Humans; Incidence; Inflammation; Interleukin-6; Lipoprotein(a); Protein C; Risk Factors; Sickle Cell Trait; Stroke; United States | 2020 |
Associations of β-Fibrinogen Polymorphisms with the Risk of Ischemic Stroke: A Meta-analysis.
Topics: Asian People; Brain Ischemia; Case-Control Studies; Fibrinogen; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Phenotype; Polymorphism, Genetic; Risk Factors; Stroke; White People | 2019 |
Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Black People; Cardiovascular Diseases; Coronary Artery Disease; Female; Fibrinogen; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Hispanic or Latino; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Factors; Stroke; Venous Thromboembolism; White People; Young Adult | 2013 |
Genetic polymorphism of β-fibrinogen gene-455G/A can contribute to the risk of ischemic stroke.
Topics: Age Factors; Alleles; Asian People; Brain Ischemia; Fibrinogen; Genetic Predisposition to Disease; Humans; Models, Genetic; Odds Ratio; Polymorphism, Genetic; Publication Bias; Risk Factors; Stroke; White People | 2014 |
Influence of the β-fibrinogen-455G/A polymorphism on development of ischemic stroke and coronary heart disease.
Topics: Case-Control Studies; Coronary Artery Disease; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Assessment; Stroke | 2014 |
Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms.
Topics: Blood Transfusion; Factor VIII; Factor XIII; Factor XIII Deficiency; Fibrinogen; Genetic Predisposition to Disease; Humans | 2014 |
The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review.
Topics: Adult; Blood Coagulation Factors; Blood Vessels; Brain Ischemia; Child; Female; Fibrinogen; Genetic Predisposition to Disease; Hemostasis; Humans; Incidence; Male; Polymorphism, Genetic; Risk Factors; Stroke | 2014 |
FGB gene - 148C>T polymorphism is associated with increased risk of ischemic stroke in a Chinese population: a meta-analysis based on 18 case-control studies.
Topics: Brain Ischemia; Case-Control Studies; China; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Humans; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Stroke | 2014 |
A polymorphism (-455G>A) in the β-fibrinogen gene is associated with an increased risk of cerebral infarction in the Chinese population: A meta-analysis.
Topics: Asian People; Cerebral Infarction; China; Fibrinogen; Genetic Heterogeneity; Genetic Predisposition to Disease; Humans; Polymorphism, Single Nucleotide; Publication Bias; Risk Factors | 2015 |
Association between the FGB gene polymorphism and ischemic stroke: a meta-analysis.
Topics: Asian People; Case-Control Studies; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Humans; Polymorphism, Single Nucleotide; Risk Factors; Stroke | 2015 |
Effect of the -148C/T, 448G/A, and -854G/A Polymorphisms of the β-Fibrinogen Gene on the Risk of Ischemic Stroke in Chinese Population.
Topics: Asian People; Brain Ischemia; Case-Control Studies; China; Fibrinogen; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Odds Ratio; Phenotype; Polymorphism, Genetic; Risk Factors; Stroke | 2015 |
Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation.
Topics: Adult; Afibrinogenemia; Blood Coagulation; Blood Coagulation Tests; DNA Mutational Analysis; Female; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Heterozygote; Humans; Mutation, Missense; Phenotype | 2017 |
Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population.
Topics: Apolipoproteins E; Asian People; Brain Ischemia; Case-Control Studies; China; Fibrinogen; Genetic Predisposition to Disease; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Odds Ratio; Peptidyl-Dipeptidase A; Periodicals as Topic; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Publication Bias; Risk Assessment; Risk Factors; Stroke | 2008 |
[Fibrinogen genes polymorphism in patients with ischemic stroke].
Topics: Brain Ischemia; DNA; Fibrinogen; Genetic Predisposition to Disease; Humans; Polymorphism, Genetic | 2008 |
Association of beta-fibrinogen gene -148C/T and -455G/A polymorphisms and coronary artery disease in Chinese population: a meta analysis.
Topics: Asian People; Coronary Artery Disease; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Phenotype; Polymorphism, Single Nucleotide; Protein Isoforms | 2008 |
Markers of early disease and prognosis in COPD.
Topics: alpha 1-Antitrypsin Deficiency; Biomarkers; C-Reactive Protein; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Denmark; Early Diagnosis; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Hospitalization; Humans; Kaplan-Meier Estimate; Mannose-Binding Lectin; Odds Ratio; Phenotype; Predictive Value of Tests; Prognosis; Pulmonary Disease, Chronic Obstructive; Registries; Risk Assessment; Risk Factors; Severity of Illness Index | 2009 |
The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.
Topics: Case-Control Studies; Factor V; Factor XIII; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Single Nucleotide; Prothrombin; Risk Factors; Venous Thromboembolism | 2009 |
Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis.
Topics: Animals; Antibody Specificity; Arthritis, Rheumatoid; Autoantibodies; Autoimmunity; Citrulline; Collagen Type II; Epitopes; Extracellular Matrix Proteins; Fibrinogen; Genetic Predisposition to Disease; Humans; Periodontitis; Phosphopyruvate Hydratase; Porphyromonas gingivalis; Protein Conformation; Protein Processing, Post-Translational; Risk Factors; Smoking; Vimentin | 2010 |
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis.
Topics: Aging; Cardiovascular Diseases; Cataract Extraction; Diabetes Complications; Evidence-Based Medicine; Eye Color; Fibrinogen; Genetic Predisposition to Disease; Humans; Macular Degeneration; Obesity; Odds Ratio; Racial Groups; Risk; Risk Factors; Sex Factors; Smoking | 2010 |
Venous thromboembolism: implications for gene-based diagnosis and technology development.
Topics: Activated Protein C Resistance; Blood Proteins; Disease Susceptibility; Epistasis, Genetic; Factor V; Female; Fibrinogen; Forecasting; Genetic Predisposition to Disease; Humans; Hyperhomocysteinemia; Male; Molecular Diagnostic Techniques; Neoplasms; Platelet Membrane Glycoproteins; Pregnancy; Pregnancy Complications, Hematologic; Prothrombin; Thromboembolism; Thrombophilia; Venous Thrombosis | 2002 |
Clinical significance of gene-diagnosis for defects in coagulation factors and inhibitors.
Topics: Adolescent; Adult; Anticoagulants; Blood Coagulation Factors; Child; DNA, Complementary; Exons; Factor IX; Factor V; Factor VIII; Factor XIII; Female; Fibrinogen; Genetic Linkage; Genetic Predisposition to Disease; Genetic Techniques; Hemophilia A; Hemophilia B; Hemorrhage; Homozygote; Humans; Introns; Logistic Models; Male; Mutation; Odds Ratio; Point Mutation; Polymorphism, Genetic; Pregnancy; Prenatal Diagnosis; Pulmonary Embolism; Risk Factors; Thrombophilia; Thrombosis; Venous Thrombosis | 2003 |
Fibrinogen, C-reactive protein and coronary heart disease: does Mendelian randomization suggest the associations are non-causal?
Topics: Biomarkers; C-Reactive Protein; Coronary Disease; Fibrinogen; Genetic Predisposition to Disease; Humans; Risk Factors | 2004 |
Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies.
Topics: Coronary Disease; Fibrinogen; Genetic Predisposition to Disease; Humans; Risk Factors; Thrombosis | 2005 |
A meta-analysis of relationship between beta-fibrinogen gene -148C/T polymorphism and susceptibility to cerebral infarction in Han Chinese.
Topics: Cerebral Infarction; China; Fibrinogen; Genetic Predisposition to Disease; Humans; Polymorphism, Genetic | 2007 |
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease.
Topics: 3' Untranslated Regions; Arterial Occlusive Diseases; Blood Coagulation Factors; Factor V; Factor VII; Factor XIII; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Hemostasis; Humans; Hyperhomocysteinemia; Plasminogen Activator Inhibitor 1; Platelet Membrane Glycoproteins; Point Mutation; Polymorphism, Genetic; Prothrombin; Receptors, Cell Surface; Risk Factors; Sequence Deletion; Thromboembolism; Thrombophilia; Tissue Plasminogen Activator; Venous Thrombosis | 2000 |
Predisposing genes, high-risk environments and coronary artery disease: LPL and fibrinogen as examples.
Topics: Coronary Artery Disease; Environment; Exercise; Fibrinogen; Genetic Predisposition to Disease; Homeostasis; Humans; Life Style; Lipoprotein Lipase; Obesity; Risk Factors; Triglycerides | 2001 |
Genes encoding fibrinogen and cardiovascular risk.
Topics: Cardiovascular Diseases; Environment; Fibrinogen; Genetic Predisposition to Disease; Humans; Polymorphism, Genetic; Risk Factors | 2001 |
Interaction of hemostatic genetics with hormone therapy: new insights to explain arterial thrombosis in postmenopausal women.
Topics: Blood Coagulation Factors; Blood Platelets; Coronary Disease; Estrogen Replacement Therapy; Factor V; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Hemostasis; Humans; Plasminogen Activator Inhibitor 1; Point Mutation; Polymorphism, Genetic; Postmenopause; Prothrombin; Thrombosis | 2002 |
Possibilities of DNA analysis for the detection of predisposition to thrombotic disease.
Topics: Biomarkers; DNA; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Plasminogen Activator Inhibitor 1; Thrombosis | 1992 |
Hereditary disorders predisposing to thrombosis.
Topics: Antithrombin III; Antithrombin III Deficiency; Blood Coagulation; Blood Proteins; Complement C4; Complement C4b; Disease Susceptibility; Enzyme Activation; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Glycoproteins; Humans; Pedigree; Plasminogen; Protein Binding; Protein C; Protein C Deficiency; Protein C Inhibitor; Protein S; Receptors, Cell Surface; Receptors, Thrombin; Thrombosis | 1986 |
4 trial(s) available for fibrinogen and Genetic Predisposition
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease.
Topics: C-Reactive Protein; Female; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Interleukin-6; Interleukin-8; Male; Middle Aged; Polymorphism, Single Nucleotide; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Quantitative Trait Loci; Tumor Necrosis Factor-alpha; Uteroglobin | 2012 |
Relationships between fibrinogen, plasminogen activator inhibitor-1, and their gene polymorphisms in current smokers with essential hypertension.
Topics: Adult; Female; Fibrinogen; Genetic Predisposition to Disease; Hemostasis; Humans; Hypertension; Male; Phenotype; Plasminogen Activator Inhibitor 1; Poland; Risk Assessment; Risk Factors; Smoking; Tissue Plasminogen Activator | 2003 |
Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Apolipoprotein C-III; Apolipoproteins C; Arterial Occlusive Diseases; Base Sequence; Bezafibrate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fibrinogen; Follow-Up Studies; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Hypolipidemic Agents; Male; Middle Aged; Molecular Sequence Data; Peripheral Vascular Diseases; Polymerase Chain Reaction; Polymorphism, Genetic; Probability; Reference Values; Sensitivity and Specificity; Treatment Outcome | 2002 |
186 other study(ies) available for fibrinogen and Genetic Predisposition
Article | Year |
---|---|
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case-control study.
Topics: Case-Control Studies; Fibrinogen; Genetic Predisposition to Disease; Hemostatics; Humans; Multiple Sclerosis; Polymorphism, Single Nucleotide | 2022 |
Structural and Functional Characterization of Four Novel Fibrinogen Mutations in
Topics: Adolescent; Afibrinogenemia; Aged; Blood Coagulation; Blood Coagulation Tests; DNA Mutational Analysis; Female; Fibrinogen; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Infant, Newborn; Male; Middle Aged; Models, Molecular; Mutation; Phenotype; Protein Conformation; Structure-Activity Relationship | 2022 |
Stat4 rs7574865 polymorphism promotes the occurrence and progression of hepatocellular carcinoma via the Stat4/CYP2E1/FGL2 pathway.
Topics: Animals; Carcinoma, Hepatocellular; Case-Control Studies; Cytochrome P-450 CYP2E1; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Liver Neoplasms; Mice; Polymorphism, Single Nucleotide; Proteomics; STAT4 Transcription Factor | 2022 |
Functional analysis of rare genetic variants in complement factor I in advanced age-related macular degeneration.
Topics: Complement Factor I; Fibrinogen; Genetic Predisposition to Disease; Heterozygote; Humans; Macular Degeneration; Polymorphism, Single Nucleotide | 2022 |
A variant rs6214 within IGF-1 confers risk for ulcerative colitis in Chinese Han populations.
Topics: Case-Control Studies; Colitis, Ulcerative; East Asian People; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Insulin; Insulin-Like Growth Factor I; MicroRNAs; Polymorphism, Single Nucleotide; Risk | 2022 |
Congenital hypofibrinogenemia associated with a novel heterozygous nonsense mutation in the globular C-terminal domain of the γ-chain (p.Glu275Stop).
Topics: Afibrinogenemia; Anticoagulants; Blood Coagulation Tests; Codon, Nonsense; Fibrinogen; Genetic Predisposition to Disease; Genetic Testing; Humans; Male; Middle Aged; Recurrence; Thrombelastography; Venous Thrombosis; Warfarin | 2020 |
Congenital structural and functional fibrinogen disorders: a primer for internists.
Topics: Adult; Afibrinogenemia; Blood Coagulation Tests; Female; Fibrinogen; Genetic Predisposition to Disease; Genetic Testing; Hemorrhage; Humans; Male; Middle Aged; Poland; Thrombosis; Young Adult | 2019 |
Relationship between fibrinogen level and its regulatory gene with Alzheimer's disease and vascular dementia.
Topics: Alzheimer Disease; Dementia, Vascular; Fibrinogen; Genes, Regulator; Genetic Predisposition to Disease; Humans | 2020 |
Correlations Between the Genetic Variations in the
Topics: Adult; Anterior Cruciate Ligament Injuries; Asian People; Case-Control Studies; China; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type V; Collagen Type XII; Cross-Sectional Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Risk Factors | 2020 |
Effect of rare coding variants in the CFI gene on Factor I expression levels.
Topics: Aged; Aged, 80 and over; Alleles; Atypical Hemolytic Uremic Syndrome; Complement Factor I; Female; Fibrinogen; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Heterozygote; Humans; Macular Degeneration; Male; Middle Aged; Polymorphism, Single Nucleotide | 2020 |
Molecular and clinical profile of congenital fibrinogen disorders in Iran, identification of two novel mutations.
Topics: Adolescent; Afibrinogenemia; Alleles; Amino Acid Substitution; Child; Child, Preschool; Female; Fibrinogen; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Heterozygote; Humans; Hydrogen Bonding; Infant; Infant, Newborn; Iran; Male; Molecular Diagnostic Techniques; Molecular Dynamics Simulation; Mutation; Phenotype; Protein Conformation; Structure-Activity Relationship | 2020 |
Do RA associated HLA-DR molecules bind citrullinated peptides or peptides from PAD4 to help the development of RA specific antibodies to citrullinated proteins?
Topics: Alleles; Amino Acid Sequence; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; Binding, Competitive; Citrullination; Epitopes; Fibrinogen; Genetic Predisposition to Disease; Genotype; HLA-DRB1 Chains; Humans; Peptides; Peptides, Cyclic; Protein Binding; Protein-Arginine Deiminase Type 4 | 2021 |
Inherited risk of dementia and the progression of cerebral small vessel disease and inflammatory markers in cognitively healthy midlife adults: the PREVENT-Dementia study.
Topics: Alzheimer Disease; Apolipoprotein E4; Biomarkers; C-Reactive Protein; Cerebral Small Vessel Diseases; Cognition; Dementia; Disease Progression; Female; Fibrinogen; Genetic Association Studies; Genetic Predisposition to Disease; Healthy Aging; Heterozygote; Humans; Inflammasomes; Male; Middle Aged; Risk; White Matter | 2021 |
An association between fibrinogen gene polymorphisms and diabetic peripheral neuropathy in young patients with type 1 diabetes.
Topics: Adolescent; Adult; Alleles; Case-Control Studies; Child; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Polymorphism, Single Nucleotide; Risk Factors; Slovakia; Young Adult | 2021 |
MMP-10 rs17435959 Polymorphism is Associated with the Formation and Stability of Carotid Atherosclerosis Plaque: A Case-Control Study.
Topics: Adult; Aged; Aged, 80 and over; Carotid Artery Diseases; Case-Control Studies; Female; Fibrinogen; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Matrix Metalloproteinase 10; Middle Aged; Phenotype; Plaque, Atherosclerotic; Polymorphism, Single Nucleotide; Prognosis; Risk Assessment; Risk Factors; Rupture, Spontaneous | 2021 |
ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.
Topics: ADAMTS13 Protein; Albuminuria; Animals; Cell Proliferation; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Extracellular Matrix; Fibrinogen; Genetic Predisposition to Disease; Kidney Glomerulus; Male; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Plasminogen Activator Inhibitor 1; Platelet Membrane Glycoprotein IIb; Streptozocin; Thrombosis; Urea; von Willebrand Factor | 2017 |
The relationship between levels of plasma-soluble urokinase plasminogen activator receptor (suPAR) and presence of migraine attack and aura.
Topics: C-Reactive Protein; Calcitonin; Female; Fibrinogen; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Migraine Disorders; Migraine with Aura; Neurogenic Inflammation; Receptors, Urokinase Plasminogen Activator | 2017 |
Hypofibrinogenaemia associated with novel Aα126Val→Asp mutation in the fibrinogen coiled coil.
Topics: Afibrinogenemia; Blood Coagulation; Child, Preschool; Fathers; Fibrinogen; Gene Expression; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Male; Mass Spectrometry; Mutation; Pedigree; Polymorphism, Genetic | 2017 |
Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study.
Topics: ABO Blood-Group System; Aged; Body Height; Case-Control Studies; Factor IX; Factor V; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Incidence; Male; Middle Aged; Norway; Phenotype; Polymorphism, Single Nucleotide; Prospective Studies; Prothrombin; Risk Assessment; Risk Factors; Venous Thromboembolism | 2018 |
A Novel Mutation in the Fibrinogen Bβ Chain (c.490G>A; End of Exon 3) Causes a Splicing Abnormality and Ultimately Leads to Congenital Hypofibrinogenemia.
Topics: Afibrinogenemia; Animals; Child, Preschool; CHO Cells; Cricetulus; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Mutation; Recombinant Proteins; Sequence Analysis, DNA | 2017 |
Research on the correlation between the fibrinogen β and attack of pediatric pneumonia.
Topics: Alleles; C-Reactive Protein; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Infant, Newborn; Interleukin-6; Male; Odds Ratio; Pneumonia; Polymorphism, Single Nucleotide; Protein Subunits | 2017 |
The β-fibrinogen gene 455G/A polymorphism associated with cardioembolic stroke in atrial fibrillation with low CHA
Topics: 5-Lipoxygenase-Activating Proteins; Aged; Atrial Fibrillation; Biomarkers; Case-Control Studies; Cross-Sectional Studies; Female; Fibrinogen; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Intracranial Embolism; Male; Matrix Metalloproteinase 9; Methylenetetrahydrofolate Reductase (NADPH2); Nitric Oxide Synthase Type III; Polymorphism, Single Nucleotide; Risk Assessment; Stroke | 2017 |
Venous thromboembolism risk associated with ABO, F11 and FGG loci.
Topics: Adolescent; Adult; Factor XI; Female; Fibrinogen; Genetic Loci; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Portugal; Venous Thromboembolism; Young Adult | 2018 |
Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism.
Topics: ABO Blood-Group System; Adult; Aged; Case-Control Studies; Factor V; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Norway; Pedigree; Polymorphism, Single Nucleotide; Prothrombin; Risk Assessment; Risk Factors; Venous Thromboembolism | 2019 |
Association of the -262C/T polymorphism in the catalase gene promoter and the C242T polymorphism of the NADPH oxidase P22phox gene with essential arterial hypertension in patients with diabetes mellitus type 2.
Topics: Aged; C-Reactive Protein; Case-Control Studies; Catalase; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genetic Predisposition to Disease; Glutathione Peroxidase; Humans; Hypertension; Male; Middle Aged; NADPH Oxidases; Oxidative Stress; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Risk Factors; Slovenia | 2014 |
Association between two functional fibrinogen-related polymorphisms and ischemic stroke: a case-control study.
Topics: Aged; Asian People; Brain Ischemia; Case-Control Studies; Female; Fibrinogen; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Stroke | 2013 |
The association between thrombophilic gene mutations and recurrent pregnancy loss.
Topics: Abortion, Habitual; Adult; Factor V; Factor VII; Factor VIII; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Integrin alpha2; Mutation; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Pregnancy; Prothrombin; Risk Factors; Thrombophilia; Young Adult | 2013 |
Identification of genetic contribution to ischemic stroke by screening of single nucleotide polymorphisms in stroke patients by using a case control study design.
Topics: Apolipoproteins E; Brain Ischemia; Case-Control Studies; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Nitric Oxide Synthase Type III; Outcome Assessment, Health Care; Polymorphism, Single Nucleotide; Stroke | 2013 |
Association of the FGA and SLC6A4 genes with autistic spectrum disorder in a Korean population.
Topics: Adolescent; Adult; Asian People; Autistic Disorder; Case-Control Studies; Epistasis, Genetic; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Phenotype; Polymorphism, Single Nucleotide; Serotonin Plasma Membrane Transport Proteins; Young Adult | 2013 |
Impact of -455G/a polymorphism of the β-fibrinogen gene on platelet aggregation in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Risk Assessment; Ticlopidine | 2014 |
Risk for early pregnancy loss by factor XIII Val34Leu: the impact of fibrinogen concentration.
Topics: Abortion, Habitual; Adult; Case-Control Studies; Factor XIII; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Odds Ratio; Polymorphism, Genetic; Risk Factors | 2013 |
Clinical, biochemical, and genetic predictors of coronary artery bypass graft failure.
Topics: Adult; Aged; Biomarkers; Case-Control Studies; Chi-Square Distribution; Coronary Angiography; Coronary Artery Bypass; Creatinine; Female; Fibrinogen; Gene Expression Profiling; Genetic Predisposition to Disease; Genome-Wide Association Study; Glutathione Transferase; Graft Occlusion, Vascular; Humans; Lipoproteins, HDL; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; Treatment Failure; Vascular Patency | 2014 |
Positive association of MMP 14 gene polymorphism with vulnerable carotid plaque formation in a Han Chinese population.
Topics: Age Factors; Aged; Asian People; Atherosclerosis; Biomarkers; Carotid Arteries; Cerebral Infarction; Female; Fibrinogen; Gene Expression; Genetic Predisposition to Disease; Humans; Male; Matrix Metalloproteinase 14; Middle Aged; Plaque, Atherosclerotic; Polymorphism, Genetic; Risk Factors | 2014 |
Combined protein- and nucleic acid-level effects of rs1143679 (R77H), a lupus-predisposing variant within ITGAM.
Topics: Alleles; Antigens, Nuclear; CD11b Antigen; Chromatin; DNA-Binding Proteins; Female; Fibrinogen; Gene Expression Regulation; Gene Frequency; Genetic Predisposition to Disease; Humans; Ku Autoantigen; Lupus Erythematosus, Systemic; Male; Monocytes; NF-kappa B p50 Subunit; Odds Ratio; Polymorphism, Genetic; Protein Binding; Racial Groups; Risk; RNA, Messenger; Trans-Activators; Transcription, Genetic; Vitronectin | 2014 |
The FGA Thr312Ala polymorphism and risk of intracerebral haemorrhage in Polish and Greek populations.
Topics: Aged; Cerebral Hemorrhage; Female; Fibrinogen; Genes, Dominant; Genetic Predisposition to Disease; Genotype; Greece; Humans; Male; Middle Aged; Poland; Polymorphism, Genetic; Regression Analysis; Risk; Stroke | 2014 |
Congenital dysfibrinogenemia coincidentally diagnosed at the onset of chronic myelogenous leukemia.
Topics: Adult; Afibrinogenemia; Fibrinogen; Genetic Predisposition to Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mutation | 2014 |
Βeta-fibrinogen gene promoter A -455 allele associated with poor longterm survival among 55-71 years old Caucasian women in Finnish stroke cohort.
Topics: Aged; Aged, 80 and over; Alleles; Cohort Studies; Female; Fibrinogen; Finland; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Stroke | 2014 |
Functionally compromised FGG variant (γ320Asp→Glu) expressed at low level in plasma fibrinogen.
Topics: Afibrinogenemia; DNA Mutational Analysis; Exons; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Models, Molecular; Mutation; Phenotype; Protein Conformation; Structure-Activity Relationship; Young Adult | 2014 |
Is there a significant lower genetic susceptibility to venous thrombosis in the Basques?
Topics: ABO Blood-Group System; Alleles; Ethnicity; Factor V; Factor XI; Fibrinogen; France; Gene Frequency; Genetic Predisposition to Disease; Humans; Polymorphism, Single Nucleotide; Prothrombin; Risk Factors; Spain; Venous Thrombosis; von Willebrand Factor | 2014 |
Prevalence of thrombophilic genetic factors among patients with retinitis pigmentosa.
Topics: Adult; DNA Mutational Analysis; Factor V; Factor XIIIa; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Plasminogen Activator Inhibitor 1; Prevalence; Receptors, Tumor Necrosis Factor, Type II; Retinitis Pigmentosa; Risk Factors; Thrombophilia; Young Adult | 2014 |
In vitro rescue of FGA deletion by lentiviral transduction of an afibrinogenemic patient's hepatocytes.
Topics: Adult; Afibrinogenemia; Cells, Cultured; Fibrinogen; Gene Deletion; Gene Expression Regulation; Genetic Predisposition to Disease; Genetic Therapy; Genetic Vectors; Hepatocytes; Homozygote; Humans; Lentivirus; Liver Transplantation; Male; Phenotype; Transduction, Genetic | 2014 |
Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency.
Topics: Adult; Afibrinogenemia; Animals; Blood Coagulation; Blood Coagulation Tests; Child; Child, Preschool; Chlorocebus aethiops; COS Cells; DNA Mutational Analysis; Female; Fibrinogen; Genetic Predisposition to Disease; HeLa Cells; Heterozygote; Homozygote; Humans; Male; Middle Aged; Mutation; Phenotype; Transfection; Young Adult | 2015 |
Analysis of risk factors of ST-segment elevation myocardial infarction in young patients.
Topics: Adult; Age Factors; Aged; Biomarkers; Female; Fibrinogen; Genetic Predisposition to Disease; Glycated Hemoglobin; Humans; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors; Sex Factors; Smoking | 2014 |
Novel FGG variant (γ339C→S) confirms importance of the γ326-339 disulphide bond for plasma expression of newly synthesised fibrinogen.
Topics: Afibrinogenemia; Blood Coagulation Tests; Blood Loss, Surgical; Disulfides; DNA Mutational Analysis; Female; Fibrinogen; Fibrinogens, Abnormal; Genetic Predisposition to Disease; Humans; Middle Aged; Mutation; N-Acetylneuraminic Acid; Phenotype; Postoperative Hemorrhage; Protein Conformation; Structure-Activity Relationship | 2015 |
[Modern methods of diagnosis of thrombophylic states and complex treatment of patients with thrombotic complications of severe forms of varicose disease].
Topics: Anticoagulants; Factor V; Factor VII; Factor XII; Female; Fibrinogen; Gene Expression; Genetic Predisposition to Disease; Humans; Integrin alpha2; Integrin beta3; Leg; Male; Middle Aged; Mutation; Plasminogen Activator Inhibitor 1; Prothrombin; Thrombophilia; Varicose Veins; Venous Thrombosis | 2014 |
The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.
Topics: Adolescent; Adult; Atypical Hemolytic Uremic Syndrome; Base Sequence; Binding Sites; Child; Complement C3; Complement Factor H; Female; Fibrinogen; Gene Expression; Genetic Predisposition to Disease; Haplotypes; Humans; Male; Membrane Cofactor Protein; Models, Molecular; Molecular Sequence Data; Mutation; Protein Binding; Protein Structure, Tertiary; Proteolysis; Recombinant Proteins; Severity of Illness Index | 2015 |
Hepatic fibrinogen storage disease: identification of two novel mutations (p.Asp316Asn, fibrinogen Pisa and p.Gly366Ser, fibrinogen Beograd) impacting on the fibrinogen γ-module.
Topics: Afibrinogenemia; Amino Acid Sequence; Child, Preschool; DNA Mutational Analysis; Female; Fibrinogen; Fibrinogens, Abnormal; Genetic Predisposition to Disease; Heterozygote; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Models, Molecular; Molecular Sequence Data; Mutation, Missense; Phenotype; Protein Conformation; Structure-Activity Relationship | 2015 |
BRCA2 gene mutations and coagulation-associated biomarkers.
Topics: Adult; alpha 1-Antitrypsin; Binding Sites; Biomarkers; Blood Coagulation; BRCA2 Protein; Breast Neoplasms; Case-Control Studies; DNA Mutational Analysis; Female; Fibrinogen; Genetic Predisposition to Disease; Haptoglobins; Heterozygote; Humans; Middle Aged; Mutation; P-Selectin; Platelet Factor 4; Rad51 Recombinase; Transferrin | 2016 |
Novel point mutation in fibrinogen (Innsbruck; BβArg44Gly). Phenotypic differences compared to another mutation (fibrinogen Nijmegen) at the same position.
Topics: Adolescent; Female; Fibrinogen; Genetic Predisposition to Disease; Hemorrhage; Humans; Phenotype; Point Mutation; Polymorphism, Single Nucleotide | 2015 |
Multiple thrombophilic single nucleotide polymorphisms lack a significant effect on outcomes in fresh IVF cycles: an analysis of 1717 patients.
Topics: Adult; Antigens, Human Platelet; Embryo Implantation; Factor V; Factor XIII; Female; Fertilization in Vitro; Fibrinogen; Genetic Predisposition to Disease; Humans; Infertility; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Plasminogen Activator Inhibitor 1; Polymorphism, Single Nucleotide; Pregnancy; Pregnancy Outcome; Prothrombin; Thrombophilia | 2016 |
Shared genetic susceptibility of vascular-related biomarkers with ischemic and recurrent stroke.
Topics: Aged; Biomarkers; Brain Ischemia; C-Reactive Protein; Female; Fibrinogen; Gene Expression; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Middle Aged; Oxidoreductases; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic; Recurrence; Stroke | 2016 |
Correlation with Platelet Parameters and Genetic Markers of Thrombophilia Panel (Factor II g.20210G>A, Factor V Leiden, MTHFR (C677T, A1298C), PAI-1, β-Fibrinogen, Factor XIIIA (V34L), Glycoprotein IIIa (L33P)) in Ischemic Strokes.
Topics: Blood Coagulation Factors; Blood Platelets; Brain Ischemia; Factor V; Factor XIIIa; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Humans; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Prothrombin; Retrospective Studies; Risk Factors; Stroke; Thrombophilia | 2016 |
Correlating blood levels of 8-hydroxydeoxyguanosine to hOGG1 genotypes and the incidence of ischemic cardiomyopathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; C-Reactive Protein; Cardiomyopathies; Case-Control Studies; Deoxyguanosine; DNA Glycosylases; Electrophoresis, Agar Gel; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; Incidence; Lipids; Male; Middle Aged; Myocardial Ischemia; Risk Factors | 2016 |
[Association between the C46T polymorphism of coagulation factor Ⅻ gene and the involvement of factor Ⅻ activity in patients with unexplained recurrent spontaneous abortion].
Topics: Abortion, Habitual; Abortion, Spontaneous; Alleles; Asian People; Case-Control Studies; China; Factor XII; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Heterozygote; Humans; Infertility; Polymorphism, Genetic; Pregnancy | 2016 |
A novel missense mutation in the FGB gene (p.Gly302Arg) leading to afibrinogenemia. Predicted structure and function consequences.
Topics: Adult; Afibrinogenemia; Base Sequence; Codon, Nonsense; Diagnosis, Differential; Fibrinogen; Genetic Predisposition to Disease; Genetic Testing; Hemorrhage; Humans; Male; Molecular Sequence Data; Rare Diseases; Structure-Activity Relationship | 2016 |
Investigation on genetic thrombophilic factors in FFPE autopsy tissue from subjects who died from pulmonary embolism.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Factor V; Factor XIII; Female; Fibrinogen; Formaldehyde; Genetic Predisposition to Disease; Glucuronidase; Heterozygote; Humans; Lipoproteins; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Paraffin Embedding; Plasminogen Activator Inhibitor 1; Polymerase Chain Reaction; Polymorphism, Genetic; Prothrombin; Pulmonary Embolism; Thrombophilia; Venous Thromboembolism | 2017 |
A Case-Control Study of the Association between Polymorphisms in the Fibrinogen Alpha Chain Gene and Schizophrenia.
Topics: Adult; Case-Control Studies; Female; Fibrinogen; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Haplotypes; Humans; Linkage Disequilibrium; Male; Polymorphism, Single Nucleotide; Schizophrenia; Sequence Analysis, DNA; Young Adult | 2017 |
Silencing of Anticoagulant Protein C Evokes Low-Incident but Spontaneous Atherothrombosis in Apolipoprotein E-Deficient Mice-Brief Report.
Topics: Animals; Antithrombin III; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Coagulation; Diet, Western; Disease Models, Animal; Female; Fibrinogen; Genetic Predisposition to Disease; Liver; Mice, Inbred C57BL; Mice, Knockout; Peptide Hydrolases; Phenotype; Plaque, Atherosclerotic; Protein C; RNA Interference; Thrombosis | 2017 |
Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome.
Topics: Adult; Complement Factor H; Complement System Proteins; DNA Mutational Analysis; Female; Fibrinogen; Genetic Predisposition to Disease; Gestational Age; HELLP Syndrome; Humans; Membrane Cofactor Protein; Mutation, Missense; Pregnancy; Risk Factors; Young Adult | 2008 |
Variation in fibrinogen FGG and FGA genes and risk of stroke: the Rotterdam Study.
Topics: Aged; Cerebral Hemorrhage; Cohort Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Haplotypes; Humans; Male; Middle Aged; Netherlands; Peptide Fragments; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Stroke | 2008 |
Linkage study of fibrinogen levels: the Strong Heart Family Study.
Topics: Adult; Arizona; Atherosclerosis; Chromosome Mapping; Cohort Studies; Female; Fibrinogen; Genetic Linkage; Genetic Predisposition to Disease; Humans; Indians, North American; Linear Models; Lod Score; Male; Middle Aged; North Dakota; Oklahoma; Risk Factors; South Dakota | 2008 |
Fibrinogen genes modify the fibrinogen response to ambient particulate matter.
Topics: Adult; Aged; Aged, 80 and over; Environmental Exposure; Europe; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homozygote; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Particulate Matter; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Urban Population | 2009 |
Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
Topics: Adult; Antiphospholipid Syndrome; Case-Control Studies; Factor XIII; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; Leucine; Male; Odds Ratio; Polymorphism, Genetic; Protein Subunits; Risk Assessment; Risk Factors; Thrombosis; Up-Regulation; Valine | 2009 |
Association study between variants in the fibrinogen gene cluster, fibrinogen levels and hypertension: results from the MONICA/KORA study.
Topics: Adult; Aged; Blood Pressure; Cross-Sectional Studies; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Germany; Haplotypes; Health Surveys; Humans; Hypertension; Male; Middle Aged; Multigene Family; Phenotype; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Sex Factors; Young Adult | 2009 |
[Genetic polymorphism and risk of arterial thrombosis in patients with atrial fibrillation].
Topics: Atrial Fibrillation; Brain Ischemia; Coronary Thrombosis; DNA; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Incidence; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Russia | 2008 |
Breathe deeply into your genes!: genetic variants and air pollution effects.
Topics: Environmental Exposure; Fibrinogen; Genetic Predisposition to Disease; Humans; Myocardial Infarction; Particulate Matter; Polymorphism, Single Nucleotide; Urban Population | 2009 |
[The beta-fibrinogen gene polymorphism, fibrinogen level and platelet aggregation in patients with ischemic stroke].
Topics: Alleles; Brain Ischemia; DNA; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Platelet Aggregation; Polymerase Chain Reaction; Polymorphism, Genetic; Prognosis; Retrospective Studies | 2008 |
Fibrinogen gene polymorphism (Bbeta-148C/T) in Uygur patients with cerebral infarction.
Topics: Adult; Aged; Aged, 80 and over; Cerebral Infarction; China; DNA Mutational Analysis; Ethnicity; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Polymorphism, Restriction Fragment Length | 2009 |
Fibrinogen, genes, and arterial stiffness.
Topics: Arteries; Compliance; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male | 2009 |
Genetic cardiovascular risk factors and age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Apolipoprotein E4; Cardiovascular Diseases; Case-Control Studies; Female; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Macular Degeneration; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Single-Blind Method; White People | 2011 |
A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.
Topics: Abortion, Habitual; Adolescent; Adult; Apolipoproteins B; Apolipoproteins E; Case-Control Studies; Factor V; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Heterozygote; Homozygote; Humans; Integrin beta3; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies; Prothrombin; Thrombophilia; Turkey; Young Adult | 2010 |
Common coding variants of the HNF1A gene are associated with multiple cardiovascular risk phenotypes in community-based samples of younger and older European-American adults: the Coronary Artery Risk Development in Young Adults Study and The Cardiovascula
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Black or African American; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Female; Fibrinogen; gamma-Glutamyltransferase; Genetic Predisposition to Disease; Genotype; Hepatocyte Nuclear Factor 1-alpha; Humans; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; White People | 2009 |
Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study.
Topics: Aged; Cardiovascular Diseases; Carotid Arteries; Female; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Humans; Interleukin-6; Male; Models, Biological; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk; Stroke | 2010 |
A genetic variant in the gene encoding fibrinogen beta chain predicted development of hypertension in Chinese men.
Topics: Amino Acid Substitution; Asian People; Biomarkers; Blood Pressure; Case-Control Studies; China; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Hypertension; Linear Models; Linkage Disequilibrium; Logistic Models; Male; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Prevalence; Risk Assessment; Risk Factors; Sex Factors; Time Factors | 2010 |
-94 ins/del ATTG NFKB1 gene variant is associated with lower susceptibility to myocardial infarction.
Topics: Aged; Biomarkers; Case-Control Studies; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; I-kappa B Proteins; Linear Models; Logistic Models; Male; Middle Aged; Myocardial Infarction; NF-kappa B p50 Subunit; NF-KappaB Inhibitor alpha; Polymorphism, Genetic | 2011 |
Does the progeny of premature ischemic stroke sufferers need intensive interest of physicians oriented toward primary prevention? A pilot study.
Topics: Adult; Age of Onset; Analysis of Variance; Biomarkers; Brain Ischemia; Case-Control Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Heredity; Homocysteine; Humans; Lipids; Logistic Models; Male; Odds Ratio; Pedigree; Phenotype; Pilot Projects; Poland; Primary Prevention; Risk Assessment; Risk Factors; Stroke; Young Adult | 2010 |
[Negative association of FGA gene 128C/G polymorphism with cerebral infarction and its effect on plasma fibrinogen in Hunan Hans].
Topics: Aged; Asian People; Cerebral Infarction; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length | 2010 |
[Relationship between fibrinogen Bß-148C/T polymorphism and coronary artery lesions in children with Kawasaki disease].
Topics: Child, Preschool; Coronary Artery Disease; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Infant; Male; Mucocutaneous Lymph Node Syndrome; Polymorphism, Genetic | 2010 |
Novel fibrinogen mutation γ314Thr→Pro (fibrinogen AI duPont) associated with hepatic fibrinogen storage disease and hypofibrinogenaemia.
Topics: Afibrinogenemia; Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Blood Coagulation; Child, Preschool; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; DNA Mutational Analysis; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Genetic Predisposition to Disease; Humans; Inclusion Bodies; International Normalized Ratio; Liver; Liver Diseases; Male; Metabolism, Inborn Errors; Models, Molecular; Mutation; Phenotype; Protein Conformation; Structure-Activity Relationship | 2010 |
Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with polymorphic fibrinogen alpha gene.
Topics: 3' Untranslated Regions; Adult; Aged; Blotting, Western; Chronic Disease; Female; Fibrinogen; Gene Expression; Genetic Predisposition to Disease; Humans; Hypertension, Pulmonary; Luciferases; Male; MicroRNAs; Middle Aged; Mutation; Polymorphism, Genetic; Pulmonary Embolism; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection | 2010 |
Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A'.
Topics: Adolescent; Adult; Afibrinogenemia; Animals; Blood Coagulation; Blood Coagulation Tests; Blotting, Western; Chlorocebus aethiops; COS Cells; DNA Mutational Analysis; Female; Fibrinogen; Fibrinogens, Abnormal; Fibrinopeptide A; Genetic Predisposition to Disease; Heterozygote; Humans; Introns; Male; Microscopy, Electron, Scanning; Mutation; Pedigree; Phenotype; Protein Multimerization; RNA Splicing; Transfection; Young Adult | 2010 |
Substitution (γ335Trp→Arg) in fibrinogen Fremantle causes diminished γ chain expression and increased sialic acid content.
Topics: Adult; Amino Acid Substitution; Arginine; Blood Coagulation; Blood Coagulation Disorders, Inherited; Female; Fibrinogen; Fibrinogens, Abnormal; Genetic Predisposition to Disease; Heredity; Humans; Middle Aged; Mutation; N-Acetylneuraminic Acid; Pedigree; Phenotype; Protein Conformation; Structure-Activity Relationship; Tryptophan | 2010 |
Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CARe).
Topics: Adult; Aged; Black or African American; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Haplotypes; Humans; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; White People | 2011 |
Platelet polymorphisms: frequency distribution and association with coronary artery disease in an Indian population.
Topics: Adult; Aged; Alleles; Blood Platelets; Case-Control Studies; Coronary Artery Disease; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; India; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Membrane Glycoproteins; Polymorphism, Single Nucleotide; Risk Factors; Severity of Illness Index; Sex Factors; Tissue Plasminogen Activator | 2011 |
Adjacent substitutions (γ352Gly→Cys and 353Thr→Pro) in fibrinogen Ilam cause diminished γ chain expression.
Topics: Adult; Amino Acid Substitution; Blood Coagulation Disorders, Inherited; Codon; DNA Mutational Analysis; Female; Fibrinogen; Fibrinogens, Abnormal; Genetic Predisposition to Disease; Humans; Infant, Newborn; Mutation; Phenotype; Protein Conformation; Protein Folding; Structure-Activity Relationship | 2011 |
The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
Topics: Aged; Analysis of Variance; Austria; Biomarkers; Blood Coagulation; Factor XIII; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms; Phenotype; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Venous Thromboembolism | 2011 |
Obesity-related derangements of coagulation and fibrinolysis: a study of obesity-discordant monozygotic twin pairs.
Topics: Abdominal Fat; Absorptiometry, Photon; Adult; Blood Coagulation; Blood Coagulation Factors; Body Composition; Body Mass Index; C-Reactive Protein; Factor IX; Factor XI; Factor XII; Fasting; Fatty Liver; Female; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Glucose Clamp Technique; Humans; Insulin Resistance; Magnetic Resonance Imaging; Male; Obesity; Plasminogen Activator Inhibitor 1; Thrombosis; Twins, Monozygotic | 2012 |
Influence of matrix metalloproteinase-12 on fibrinogen level.
Topics: Animals; Atherosclerosis; England; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Homozygote; Humans; Italy; Linear Models; Linkage Disequilibrium; Logistic Models; Matrix Metalloproteinase 12; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors | 2012 |
Fibrinogen polymorphisms associated with sporadic cerebral hemorrhage in a Chinese population.
Topics: Aged; Asian People; Case-Control Studies; Cerebral Hemorrhage; China; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide | 2012 |
A genetic instrument for Mendelian randomization of fibrinogen.
Topics: Alleles; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; Mendelian Randomization Analysis; Middle Aged; Multigene Family; Polymorphism, Single Nucleotide; Prospective Studies; Survival Analysis; United Kingdom | 2012 |
Lack of association between polymorphisms of thrombogenic genes and disease susceptibility in rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Autoantibodies; Factor V; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Peptides, Cyclic; Plasminogen Inactivators; Polymorphism, Single Nucleotide; Prothrombin | 2013 |
Multiple gene polymorphisms predisposing to the prothrombotic state in an adolescent with acute myocardial infarction.
Topics: Adolescent; Anticoagulants; Aspirin; Cholesterol Ester Transfer Proteins; Clopidogrel; Coronary Angiography; Electrocardiography; Fibrinogen; Genetic Predisposition to Disease; Heparin; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Thrombosis; Ticlopidine | 2012 |
Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Analysis of Variance; Apolipoprotein E4; Biomarkers; Black or African American; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; Inflammation; Inflammation Mediators; Phenotype; Phospholipases A2; Risk Assessment; Risk Factors; Serum Amyloid A Protein; Serum Amyloid P-Component; United States; White People | 2012 |
Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile.
Topics: Arthritis, Rheumatoid; Autoantibodies; Case-Control Studies; Citrulline; Collagen Type II; Cross Reactions; Epitopes; Fibrinogen; Genetic Predisposition to Disease; Genotype; HLA-DRB1 Chains; Humans; Logistic Models; Peptides; Phosphopyruvate Hydratase; Protein Tyrosine Phosphatase, Non-Receptor Type 22; Risk Factors; Seroepidemiologic Studies; Smoking; Sweden; Vimentin | 2013 |
[Gene-determined hemocoagulation disease as a cause of ischemic stroke in children].
Topics: Alleles; Blood Coagulation Disorders; Child; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Integrin alpha2; Male; Mutation; Plasminogen Activator Inhibitor 1; Stroke; Thrombosis | 2011 |
Fibrinogen Gdansk: hypofibrinogenemia associated with a novel missense mutation in FGA (Ser112Pro).
Topics: Adult; Afibrinogenemia; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Mutation, Missense | 2012 |
[Association between gene polymorphisms and myocardial infarction in Han Chinese of Yunnan province].
Topics: Adult; Aged; Aged, 80 and over; China; Factor VII; Factor XII; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic | 2012 |
The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is associated with fibrinogen plasma levels in postmenopausal women.
Topics: Alu Elements; Body Mass Index; Cardiovascular Diseases; Estrogen Receptor beta; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Middle Aged; Polymorphism, Genetic; Postmenopause; Prognosis; Risk Factors | 2012 |
Myocardial infarction marker levels are influenced by prothrombin and tumor necrosis factor-α gene polymorphisms in young patients.
Topics: Adult; Age Factors; Biomarkers; Creatine Kinase, MB Form; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Prothrombin; Troponin; Tumor Necrosis Factor-alpha; Young Adult | 2013 |
Heterogeneity of platelet functional alterations in patients with filamin A mutations.
Topics: Blood Platelets; Blotting, Western; Cell Shape; Collagen; Contractile Proteins; Crotalid Venoms; Cytoskeleton; Dose-Response Relationship, Drug; Female; Fibrinogen; Filamins; Genetic Predisposition to Disease; Heterozygote; Humans; Lectins, C-Type; Microfilament Proteins; Muscular Dystrophies; Mutation; Phenotype; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Signal Transduction; Thrombocytopenia; Thrombosis; von Willebrand Factor | 2013 |
Presence and role of anti-citrullinated protein antibodies in experimental arthritis models.
Topics: Adjuvants, Immunologic; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; Citrulline; Collagen Type II; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; False Positive Reactions; Fibrinogen; Freund's Adjuvant; Genetic Predisposition to Disease; Immunotherapy, Active; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Myelin Basic Protein; Protein Processing, Post-Translational; Proteins | 2013 |
Thrombosis in association with a novel substitution (γ346Gly→Val) at an absolutely conserved site in the fibrinogen γ chain.
Topics: Blood Coagulation; Blood Coagulation Tests; Conserved Sequence; DNA Mutational Analysis; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Mutation; Peptide Fragments; Phenotype; Venous Thrombosis; Young Adult | 2013 |
Molecular analysis of thrombophilic risk factors in patients with dural arteriovenous fistulas.
Topics: Aged; Case-Control Studies; Central Nervous System Vascular Malformations; Cranial Sinuses; Factor V; Factor XIII; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Protein C; Prothrombin; Risk Factors; Thrombophilia | 2002 |
Fibrinogen and factor VII promoter polymorphisms in women with preeclampsia.
Topics: Adult; Case-Control Studies; Factor VII; Female; Fibrinogen; Gene Expression; Genetic Markers; Genetic Predisposition to Disease; Humans; Polymorphism, Genetic; Pre-Eclampsia; Pregnancy; Probability; Promoter Regions, Genetic; Reference Values; Retrospective Studies; Sensitivity and Specificity | 2002 |
Fibrinogen--the key to familial CHD or just another shadow in Plato's allegory?
Topics: Biomarkers; Coronary Disease; Fibrinogen; Genetic Predisposition to Disease; Humans; Prognosis; Risk Factors | 2002 |
Elevated fibrinogen in the healthy male relatives of patients with severe, premature coronary artery disease.
Topics: Adolescent; Adult; Age of Onset; Aged; Case-Control Studies; Coronary Disease; Factor VII; Fibrinogen; Genetic Predisposition to Disease; Humans; Linear Models; Male; Middle Aged; Risk Factors; von Willebrand Factor | 2002 |
Von Willebrand factor, fibrinogen and other risk factors of thrombosis in patients with a history of cerebrovascular ischemic stroke and their children.
Topics: Adult; Age Distribution; Analysis of Variance; Biomarkers; Blood Chemical Analysis; Blood Pressure Determination; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Incidence; Male; Middle Aged; Predictive Value of Tests; Probability; Reference Values; Risk Factors; Sensitivity and Specificity; Sex Distribution; Statistics, Nonparametric; Stroke; Thrombosis; von Willebrand Factor | 2002 |
Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bbeta-chain gene causing activation of cryptic splice sites.
Topics: Adolescent; Afibrinogenemia; Base Sequence; Blood Coagulation Tests; Child, Preschool; Cloning, Molecular; Consanguinity; DNA Mutational Analysis; Fibrinogen; Genetic Predisposition to Disease; HeLa Cells; Hemorrhagic Disorders; Humans; Introns; Iran; Italy; Male; Molecular Sequence Data; Mutagenesis, Site-Directed; Pedigree; Protein Conformation; Reverse Transcriptase Polymerase Chain Reaction; RNA Splice Sites; RNA Splicing; Transcription, Genetic; Transfection | 2002 |
Does plasma fibrinogen increase thrombotic tendency?
Topics: Fibrinogen; Genetic Predisposition to Disease; Humans; Polymorphism, Genetic; Risk; Venous Thrombosis | 2002 |
G-455A polymorphism of the fibrinogen beta gene and deep vein thrombosis.
Topics: Alleles; Case-Control Studies; Fibrinogen; Genes, APC; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Polymorphism, Genetic; Risk Factors; Venous Thrombosis | 2002 |
Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction.
Topics: Animals; Endomyocardial Fibrosis; Factor VII; Fibrinogen; Gene Expression; Genetic Predisposition to Disease; Hemophilia B; Hemorrhagic Disorders; Hemosiderin; Hemostasis; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Models, Biological; Muscle, Skeletal; Myocardium; Organ Specificity; Protein Structure, Tertiary; Recombinant Fusion Proteins; Thromboplastin; Ventricular Dysfunction, Left | 2002 |
Prenatal diagnosis for congenital afibrinogenemia caused by a novel nonsense mutation in the FGB gene in a Palestinian family.
Topics: Abortion, Spontaneous; Afibrinogenemia; Amino Acid Sequence; Amniocentesis; Arabs; Codon; Codon, Nonsense; Consanguinity; DNA, Complementary; Female; Fetal Diseases; Fibrinogen; Genes, Recessive; Genetic Predisposition to Disease; Hemorrhagic Disorders; Humans; Infant, Newborn; Male; Molecular Sequence Data; Pedigree | 2003 |
Fibrinogen gene promoter -455 A allele as a risk factor for lacunar stroke.
Topics: Aged; Alleles; Brain Infarction; Cerebral Arteries; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Risk Factors; Stroke | 2003 |
A genome-wide search for genes affecting circulating fibrinogen levels in the Framingham Heart Study.
Topics: Adult; Arteriosclerosis; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 7; Cohort Studies; Coronary Disease; Diabetes Mellitus; Family Health; Female; Fibrinogen; Genetic Predisposition to Disease; Genome, Human; Genotype; Humans; Hypertension; Lod Score; Male; Middle Aged; Obesity; Polymorphism, Restriction Fragment Length; Risk Factors | 2003 |
Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines.
Topics: Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Coronary Artery Disease; Cytokines; Environmental Exposure; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Immunoglobulin A; Immunoglobulin G; Infections; Inflammation; Interleukin-6; Male; Middle Aged; Polymorphism, Genetic; Prevalence; Prognosis; Risk Factors; Tumor Necrosis Factor-alpha | 2003 |
Risk-factor profile in severe, generalized, obliterating vascular disease.
Topics: Aged; Apolipoproteins E; Arteriosclerosis Obliterans; Factor V; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Polymorphism, Genetic; Risk Factors | 2004 |
-455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications.
Topics: 3' Untranslated Regions; Abruptio Placentae; Adolescent; Adult; Alleles; Amino Acid Substitution; DNA Mutational Analysis; Ethnicity; Factor V; Female; Fetal Death; Fetal Growth Retardation; Fibrinogen; Genetic Predisposition to Disease; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Placental Circulation; Point Mutation; Polymorphism, Genetic; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Prevalence; Prothrombin; Thrombophilia | 2004 |
Beta-fibrinogen promoter -455 G/A (HaeIII) polymorphism prediction of plasma fibrinogen but not of ischemic cerebrovascular disease.
Topics: Alleles; Cerebrovascular Disorders; Female; Fibrinogen; Genetic Predisposition to Disease; Homozygote; Humans; Male; Middle Aged; Polymorphism, Restriction Fragment Length; Risk Factors | 2004 |
Plasma fibrinogen levels are associated with a strong family history of myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Apolipoprotein A-I; Case-Control Studies; Comorbidity; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Parents; Risk Factors; Sampling Studies; Siblings | 2004 |
Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
Topics: Aged; Aged, 80 and over; Alleles; Amino Acid Substitution; Atrial Fibrillation; Factor XIII; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Inflammation; Interleukin-6; Male; P-Selectin; Polymorphism, Genetic; Thromboplastin | 2004 |
Evidence for association between endothelial nitric oxide synthase gene polymorphism (G894T) and inflammatory markers: the ATTICA study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Cross-Sectional Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Homocysteine; Humans; Leukocyte Count; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Point Mutation; Polymorphism, Genetic; Serum Amyloid A Protein | 2004 |
[Association of polymorphic marker G(-455)A of gene FGB with coronary artery disease].
Topics: Alleles; Coronary Disease; Female; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Male; Moscow; Myocardial Infarction; Polymorphism, Single Nucleotide | 2004 |
Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of beta-fibrinogen genotype and environmental factors. The HIFMECH Study.
Topics: Aged; Alleles; Body Mass Index; Case-Control Studies; Environment; Europe; Exons; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Interleukin-6; Introns; Male; Middle Aged; Models, Genetic; Myocardial Infarction; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Regression Analysis; Reverse Transcriptase Polymerase Chain Reaction; Risk; Smoking; Time Factors; Venous Thrombosis | 2004 |
Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.
Topics: Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Fibrinogen; Genetic Predisposition to Disease; Hemostasis; Humans; Hypertension; Male; Peptidyl-Dipeptidase A; Perindopril; Phenotype; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Treatment Outcome | 2004 |
The -455G/A polymorphism of the beta fibrinogen gene and the Bgl II polymorphism of the alpha2beta1 integrin gene and myocardial infarction in patients with type 2 diabetes.
Topics: Bacterial Proteins; Deoxyribonucleases, Type II Site-Specific; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Integrin alpha2beta1; Male; Myocardial Infarction; Polymorphism, Genetic; White People | 2004 |
A genome search for genetic determinants that influence plasma fibrinogen levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fibrinogen; Gene Expression Profiling; Genetic Predisposition to Disease; Genomics; Haplotypes; Humans; Infant; Linkage Disequilibrium; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; Thrombosis | 2005 |
Genetic and environmental origins of the association between birth weight and cardiovascular risk factors.
Topics: Birth Weight; Cardiovascular Diseases; Environmental Exposure; Fibrinogen; Genetic Predisposition to Disease; Humans; Hypertension; Risk Factors; Twin Studies as Topic | 2005 |
The effect of birth weight on clottable and intact fibrinogen levels: a twin study.
Topics: Adult; Birth Weight; Case-Control Studies; Databases, Factual; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Linear Models; Male; Middle Aged; Thrombophilia; Twins, Dizygotic; Twins, Monozygotic | 2005 |
Beta-fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohort.
Topics: Adult; Aged; Alleles; Cardiovascular Diseases; Cohort Studies; Comorbidity; Diabetes Mellitus; Ethnicity; Female; Fibrinogen; Follow-Up Studies; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Inflammation; Kidney Failure, Chronic; Male; Middle Aged; Polymorphism, Genetic; Renal Dialysis; Risk; Smoking | 2005 |
[Assessment of metabolic atherosclerosis risk factors in progeny of patients with past ischemic stroke].
Topics: Adult; Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Female; Fibrinogen; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Life Style; Lipoprotein(a); Male; Risk Factors; Stroke; Time Factors; Triglycerides; von Willebrand Factor | 2005 |
[Correlation between fibrinogen polymorphisms and the type of cerebral infarction].
Topics: Aged; Cerebral Infarction; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length | 2005 |
Genetic risk factors for arterial thrombosis and inflammation.
Topics: Arteries; Factor V; Factor VIII; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Hemostasis; Humans; Inflammation; Myocardial Infarction; Risk Factors; Stroke; Thrombosis | 2005 |
Functional polymorphisms of FGA, encoding alpha fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population.
Topics: Adult; Aged; Alleles; Cell Line, Tumor; DNA Mutational Analysis; Female; Fibrinogen; Gene Expression; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Luciferases; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Single-Stranded Conformational; Promoter Regions, Genetic; Protein Subunits; Recombinant Fusion Proteins; Taiwan; Thromboembolism; Venous Thrombosis | 2006 |
Fibrinogen and CRP in Israeli families: genetic and environmental sources of concentrations and longitudinal changes.
Topics: Adult; Biomarkers; C-Reactive Protein; Environmental Exposure; Environmental Illness; Female; Fibrinogen; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Incidence; Israel; Male; Middle Aged; Phenotype; Retrospective Studies; Risk Factors | 2006 |
Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease.
Topics: Aged; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Interleukin-6; Male; Middle Aged; Peripheral Vascular Diseases; Polymorphism, Genetic; Vascular Endothelial Growth Factor A | 2006 |
Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction.
Topics: Environment; Epistasis, Genetic; Factor XIII; Fibrin; Fibrinogen; Gels; Genetic Markers; Genetic Predisposition to Disease; Humans; Middle Aged; Models, Genetic; Myocardial Infarction; Polymorphism, Single Nucleotide; Porosity; Risk Factors | 2006 |
Hypofibrinogenaemia resulting from novel single nucleotide deletion at codon Bbeta58 (3404del A) associated with thrombotic stroke in infancy.
Topics: Adolescent; Adult; Afibrinogenemia; Amino Acid Sequence; Base Sequence; Family Health; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Molecular Sequence Data; Point Mutation; Stroke; Thrombosis | 2006 |
[A linkage between beta-fibrinogen gene -148C/T polymorphism and cerebral infarction].
Topics: Adult; Aged; Aged, 80 and over; Alleles; Asian People; Cerebral Infarction; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Polymorphism, Genetic; Stroke; Young Adult | 2006 |
Common genetic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk.
Topics: Aged; Base Sequence; Blood Proteins; Cardiovascular Diseases; Chromosome Mapping; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Haplotypes; Hemostatics; Humans; Linkage Disequilibrium; Male; Middle Aged; Molecular Sequence Data; Multigene Family; Plasminogen Activators; Polymorphism, Single Nucleotide; Thrombosis | 2006 |
Randomised by (your) god: robust inference from an observational study design.
Topics: Aged; Alcohol Drinking; Cardiovascular Diseases; Cholesterol; Epidemiologic Research Design; Female; Fibrinogen; Genetic Predisposition to Disease; Heredity; Humans; Male; Middle Aged; Neural Tube Defects; Risk | 2006 |
Analysis of the effect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort. The role of FGB-455 G/A polymorphism.
Topics: Adenine; Adult; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Fasting; Female; Fibrinogen; France; Gene Frequency; Genetic Predisposition to Disease; Genotype; Guanine; Homeostasis; Humans; Immunoenzyme Techniques; Insulin; Male; Metabolic Syndrome; Middle Aged; Polymorphism, Single Nucleotide; Reference Values; Risk Factors | 2007 |
Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study.
Topics: Adolescent; Adult; Black or African American; Blood Coagulation Tests; Cardiovascular Diseases; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Haplotypes; Humans; Immunoassay; Linkage Disequilibrium; Phenotype; Polymorphism, Single Nucleotide; Reproducibility of Results; White People | 2006 |
[Study on the relationship between polymorphisms of susceptible genes in coagulation pathway related to pulmonary thromboembolism in Chinese Han population].
Topics: Asian People; Case-Control Studies; China; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Linkage Disequilibrium; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Pulmonary Embolism; Risk Factors | 2006 |
[A related analysis for alpha, beta fibrinogen gene haplotypes and nucleotide polymorphisms associated with the ischemic stroke in Hainan Han population].
Topics: Alleles; Brain Ischemia; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Linkage Disequilibrium; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Stroke | 2006 |
Commentary: fibrinogen and coronary heart disease--test of causality by 'Mendelian' randomization by Keavney et al.
Topics: Coronary Disease; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Meta-Analysis as Topic; Polymorphism, Genetic; Risk Assessment | 2006 |
Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.
Topics: Arterial Occlusive Diseases; Blood Coagulation Factors; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Germany; Humans; Integrin alpha2; Lipoproteins; Methylenetetrahydrofolate Reductase (NADPH2); Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Single Nucleotide; Serine Endopeptidases; Thromboembolism; Thrombophilia; Tissue Plasminogen Activator; Venous Thrombosis | 2006 |
Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
Topics: Adolescent; Adult; Aged; Child; Complement C3; Complement C3 Nephritic Factor; Complement Factor H; Complement Pathway, Alternative; Female; Fibrinogen; Genetic Predisposition to Disease; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Hemolytic-Uremic Syndrome; Humans; Male; Membrane Cofactor Protein; Mesangial Cells; Middle Aged; Retrospective Studies; Risk Factors | 2007 |
TagSNP evaluation for the association of 42 inflammation loci and vascular disease: evidence of IL6, FGB, ALOX5, NFKBIA, and IL4R loci effects.
Topics: Aged; Aged, 80 and over; Arachidonate 5-Lipoxygenase; Carotid Stenosis; Case-Control Studies; DNA-Binding Proteins; Female; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Humans; I-kappa B Proteins; Inflammation; Interleukin-6; Longitudinal Studies; Male; Middle Aged; NF-KappaB Inhibitor alpha; Polymorphism, Single Nucleotide; Receptors, Interleukin-4 | 2007 |
Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors.
Topics: Female; Fibrin; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Models, Genetic; Myocardial Infarction; Peptide Fragments; Polymorphism, Genetic; Protein Isoforms; Risk; Risk Factors; RNA, Messenger | 2007 |
Fibrinogen gene haplotypes in relation to risk of coronary events and coronary and extracoronary atherosclerosis: the Rotterdam Study.
Topics: Aged; Aortic Diseases; Calcinosis; Carotid Artery Diseases; Cohort Studies; Coronary Artery Disease; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Male; Middle Aged; Netherlands; Odds Ratio; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies; Risk Factors; Time Factors | 2007 |
Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the risk of venous thrombosis.
Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Homozygote; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Introns; Male; Middle Aged; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Receptors, Interleukin-1 Type I; Receptors, Interleukin-1 Type II; Risk Assessment; Risk Factors; Venous Thrombosis | 2007 |
The fibrinogen gamma (FGG) 10034C>T polymorphism is associated with venous thrombosis.
Topics: Adult; Aged; Austria; Case-Control Studies; DNA Mutational Analysis; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Polymorphism, Single Nucleotide; Risk Factors; Venous Thrombosis | 2007 |
Epistatic effect of plasminogen activator inhibitor 1 and beta-fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: interaction with environmental/clinical factors.
Topics: Adolescent; Adult; Alleles; Cohort Studies; Cross-Sectional Studies; Epistasis, Genetic; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Kidney Glomerulus; Logistic Models; Lupus Nephritis; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Risk Factors; Thrombosis | 2007 |
Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
Topics: Age of Onset; Child; Complement Factor H; Female; Fibrinogen; Genetic Predisposition to Disease; Hemolytic-Uremic Syndrome; Humans; Infant; Kidney Transplantation; Male; Membrane Cofactor Protein; Plasma; Point Mutation; Postoperative Complications; Prognosis; Risk Factors; Thrombosis; Treatment Outcome | 2007 |
Platelet activation, myocardial ischemic events and postoperative non-response to aspirin in patients undergoing major vascular surgery.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Myocardial Ischemia; P-Selectin; Platelet Activation; Vascular Surgical Procedures | 2007 |
Clinical and biological features of 3 cases of hypofibrinogenemia associated with three different mutations (gamma Ala341Thr, Bbeta Tyr326Cys and Aalpha Asp496Asn).
Topics: Adult; Afibrinogenemia; Blood Coagulation; Blood Coagulation Tests; DNA Mutational Analysis; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Models, Molecular; Mutation; Pedigree; Phenotype; Pregnancy; Protein Conformation | 2007 |
Heritability of clot formation, morphology, and lysis: the EuroCLOT study.
Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Cardiovascular Diseases; Europe; Female; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Genetic Variation; Humans; Male; Metabolic Syndrome; Middle Aged; Nephelometry and Turbidimetry; Pedigree; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombosis; Time Factors | 2007 |
Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.
Topics: Adult; Female; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Fibrinopeptide A; Genetic Predisposition to Disease; Genotype; Humans; Phenotype; Polymers; Polymorphism, Single Nucleotide | 2007 |
Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles.
Topics: Alleles; Antibodies, Anti-Idiotypic; Antibody Specificity; Arthritis, Rheumatoid; Citrulline; Cohort Studies; Epitopes; Fibrinogen; Genetic Predisposition to Disease; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Vimentin | 2007 |
Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension.
Topics: Adult; Aged; Cohort Studies; Factor V; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Hypertension, Pulmonary; Male; Middle Aged; Polymorphism, Single Nucleotide; Thromboembolism | 2008 |
Cardiovascular risk factors in obese women and their first-degree relatives.
Topics: Adult; Aged; Anthropometry; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Family; Female; Fibrinogen; Genetic Predisposition to Disease; Heart Rate; Humans; Insulin; Linear Models; Lipids; Male; Middle Aged; Obesity; Risk Factors; Triglycerides; Turkey | 2007 |
Evidence of major genes effects on serum homocysteine and fibrinogen levels, and premature ischemic heart disease in Italian extended families.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fibrinogen; Genetic Predisposition to Disease; Homocysteine; Humans; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Myocardial Ischemia; Parents; Pedigree; Polymorphism, Single Nucleotide; Risk Factors; Siblings | 2008 |
Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study.
Topics: Age Factors; Aged; Black or African American; Brain Ischemia; Cardiovascular Diseases; Carotid Artery Diseases; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Male; Myocardial Infarction; Polymorphism, Single Nucleotide; Population Surveillance; Proportional Hazards Models; Prospective Studies; Reproducibility of Results; Risk Assessment; Risk Factors; Sex Factors; Stroke; United States; White People | 2008 |
Interleukin-6-572C>G polymorphism-association with inflammatory variables in Korean men with coronary artery disease.
Topics: Adult; Asian People; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Inflammation Mediators; Interleukin-6; Korea; Lipids; Male; Middle Aged; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Reference Values | 2008 |
Polymorphisms in coagulation factors and the risk of recurrent cardiovascular events in men after a first myocardial infarction.
Topics: Adult; Aged; Blood Coagulation Factors; Cardiovascular Diseases; Cohort Studies; DNA Mutational Analysis; Fibrinogen; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Recurrence; Risk Factors | 2008 |
Polymorphisms in the IL6 gene in Asian Indian families with premature coronary artery disease--the Indian Atherosclerosis Research Study.
Topics: Adult; Age of Onset; Aged; Asian People; C-Reactive Protein; Case-Control Studies; Coronary Artery Disease; DNA Mutational Analysis; Female; Fibrinogen; Genetic Linkage; Genetic Predisposition to Disease; Haplotypes; Humans; India; Interleukin-6; Lod Score; Male; Middle Aged; Odds Ratio; Pedigree; Phenotype; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Quantitative Trait Loci; Risk Assessment; Risk Factors | 2008 |
Three German fibrinogen Aalpha-chain amyloidosis patients with the p.Glu526Val mutation.
Topics: Amyloidosis; Biopsy; Diagnosis, Differential; Exons; Female; Fibrinogen; Genetic Predisposition to Disease; Germany; Humans; Kidney; Male; Middle Aged; Mutation; Pedigree; White People | 2008 |
Polymorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples.
Topics: Aged; Alleles; Asian People; Base Sequence; Body Mass Index; Coronary Disease; Diet; Disease Susceptibility; Estrogen Replacement Therapy; Female; Fibrinogen; Gene Frequency; Genes; Genetic Predisposition to Disease; Genotype; Habits; Humans; Japan; Male; Menopause; Middle Aged; Molecular Sequence Data; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reference Values; Risk Factors; Triglycerides; United States; White People | 1995 |
Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients.
Topics: Alleles; Base Sequence; Coronary Disease; Fibrinogen; Gene Frequency; Genes; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Molecular Sequence Data; Polymorphism, Restriction Fragment Length | 1995 |
Fibrinogen plasma levels in an apparently healthy general population--relation to environmental and genetic determinants.
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Alleles; Body Mass Index; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Italy; Life Style; Lipids; Male; Middle Aged; Myocardial Ischemia; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Reference Values; Risk Factors; Smoking | 1998 |
[Comparative study of peripheral circulation, lipid metabolism and hemocoagulation in families with atherosclerosis and diabetes mellitus].
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Blood Circulation; Blood Coagulation; Child; Cholesterol, HDL; Diabetes Mellitus; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Lipids; Male; Middle Aged; Triglycerides | 1998 |
Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation.
Topics: Amino Acid Substitution; Atrial Fibrillation; Brain Ischemia; Comorbidity; Coronary Disease; Diabetes Mellitus; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Hypertension; Male; Point Mutation; Polymorphism, Genetic; Risk; Risk Factors; Smoking; Survival Analysis; Thromboembolism; Thrombophilia; Transglutaminases | 1999 |
Helicobacter pylori infection and the risk of myocardial infarction: role of fibrinogen and its genetic control.
Topics: Adult; Aged; Alleles; Case-Control Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Risk Factors | 1999 |
Beta-fibrinogen gene G/A-455 polymorphism in relation to fibrinogen concentrations and ischaemic heart disease in Chinese patients with type II diabetes.
Topics: Age Factors; Alleles; Body Mass Index; China; Cohort Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Gene Frequency; Genetic Linkage; Genetic Predisposition to Disease; Genotype; Humans; Logistic Models; Male; Middle Aged; Myocardial Ischemia; Polymorphism, Genetic; Risk Factors; Sex Factors; Smoking | 1999 |
Contribution of the -455G/A polymorphism at the beta-fibrinogen gene to erythrocyte aggregation in patients with coronary artery disease.
Topics: 5' Untranslated Regions; Adult; Comorbidity; Coronary Disease; Erythrocyte Aggregation; Female; Fibrinogen; Gene Expression Regulation; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Linkage Disequilibrium; Male; Middle Aged; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Quebec; Smoking | 1999 |
The Pl(A2) allele and cardiovascular disease: the pro(33) and con.
Topics: Alleles; Amino Acid Substitution; Antigens, Human Platelet; Cardiovascular Diseases; Cell Adhesion Molecules; Clot Retraction; Fibrinogen; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Genetic Predisposition to Disease; Humans; Male; Phosphorylation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Point Mutation; Polymorphism, Genetic; Protein Isoforms; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Risk Factors | 2000 |
The Pl(A2) polymorphism of integrin beta(3) enhances outside-in signaling and adhesive functions.
Topics: Actins; Alleles; Amino Acid Substitution; Animals; Antigens, Human Platelet; Biopolymers; Cell Adhesion Molecules; Cell Line; Cell Size; CHO Cells; Clot Retraction; Coronary Disease; Cricetinae; Cricetulus; Cytochalasin D; Cytoskeleton; Female; Fibrinogen; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Genetic Predisposition to Disease; Humans; Kidney; Male; Phosphorylation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Point Mutation; Polymorphism, Genetic; Protein Isoforms; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Risk Factors; Signal Transduction | 2000 |
Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Black People; Case-Control Studies; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Regression Analysis; Risk Factors; United States; Venous Thrombosis | 2000 |
Racial and genetic determinants of plasma factor XIII activity.
Topics: Adult; Asian People; China; Coronary Disease; Factor XIII; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Plasminogen; Polymorphism, Genetic; Risk Assessment; White People | 2000 |
Age and sex differences in the relationship between inherited and lifestyle risk factors and subclinical carotid atherosclerosis: the Tromsø study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Arteriosclerosis; Carotid Arteries; Carotid Artery Diseases; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Life Style; Male; Middle Aged; Norway; Prevalence; Retrospective Studies; Risk Factors; Sex Characteristics; Sex Factors; Surveys and Questionnaires; Triglycerides; Tunica Intima; Ultrasonography | 2001 |
Inherited complete factor I deficiency associated with systemic lupus erythematosus, higher susceptibility to infection and low levels of factor H.
Topics: Adult; Bacterial Infections; Cell Migration Inhibition; Cells, Cultured; Child, Preschool; Coagulation Protein Disorders; Complement Activation; Complement C3; Complement C3b; Complement Factor H; Family Health; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Immunoelectrophoresis, Two-Dimensional; Lupus Erythematosus, Systemic; Phagocytosis | 2001 |
Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart Study.
Topics: Adenosine Diphosphate; Alleles; Antigens, Human Platelet; Cardiovascular Diseases; Epinephrine; Epitopes; Female; Fibrinogen; Gene Frequency; Genetic Linkage; Genetic Predisposition to Disease; Genetic Testing; Genotype; Homozygote; Humans; Integrin beta3; Male; Middle Aged; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Risk Factors; Vasoconstrictor Agents; von Willebrand Factor | 2001 |
Genetic and immunological characterization of fibrinogen inclusion bodies in patients with hepatic fibrinogen storage and liver disease.
Topics: Fibrinogen; Genetic Predisposition to Disease; Humans; Immunohistochemistry; Liver; Liver Cirrhosis; Liver Diseases | 2001 |
Cardiovascular risk factors associated with insulin resistance cluster in families with early-onset coronary heart disease.
Topics: Adult; Age of Onset; Aged; Arteriosclerosis; Cardiovascular Diseases; Cholesterol, HDL; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Insulin Resistance; Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Risk Factors; Triglycerides | 2001 |
Fibrinogen genotypes (alpha and beta) are associated with plasma fibrinogen levels in Chinese.
Topics: Adult; Aged; Analysis of Variance; Asian People; China; Coronary Disease; Environment; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Linkage Disequilibrium; Male; Middle Aged; Polymorphism, Restriction Fragment Length; Risk Factors; Singapore; Smoking | 2001 |
Lp(a), homocysteine and a family history of early ischemic cerebral stroke.
Topics: Adolescent; Adult; Brain Ischemia; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Regression Analysis; Risk Factors; Severity of Illness Index; Stroke; Uric Acid | 2001 |